Embed Size (px)
Citation preview
44th ANNUAL MEETING
ASSOCIATION FOREUROPEAN PAEDIATRIC CARDIOLOGY
MAY 26-29, 2010INNSBRUCK, AUSTRIA www.aepc2010.at
J O I N T S E S S I O N W I T H
Japanese Society of Pediatric
Cardiology and Cardiac Surgery
2
3
CONTENTS
Welcome .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Committees .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Important Addresses .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
General Information .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Information for Authors and Chairpersons .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Programme Overview .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Administrative Meetings .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Agenda AEPC Business Meeting Innsbruck .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Scientifi c Programme... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Wednesday .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Thursday .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Friday .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Saturday .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
List of Posters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
Social Programme .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
Tours and Excursions .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
Exhibitors and Sponsors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
4
WELCOME
Dear colleagues and friends,
It is a great pleasure and honour for Paediatric Cardiology in Austria welcoming you to the 44th Annual Meeting of the Association of European Paediatric Cardiology in Innsbruck.
Being a small country in the middle of Europe we are very proud giving the opportu-nity to connect Europe’s East and West.
The scientifi c programme follows the general themes “Quality of life - ethical issues – intercultural aspects”.
You will fi nd those addressed within the Joint sessions, key note lectures and Working Group sessions.
The oral abstract sessions as well as the Poster presentations will give a representa-tive overview of the latest innovations and results accomplished by the international scientifi c community. Presenters and participants come from all over the world and will create a dynamic and exhilarating atmosphere for discussion, networking and socialising.
We are very happy to have for the fi rst time representatives of the Japanese Society of Paediatric Cardiology and Cardiac Surgery as Guest faculty with us, enriching the programme with their contributions!
The Update course by the WG Dysrhythmia and Electrophysiology and the Hands-on session by the WG Morphology cover the educational part of the programme.
The programme gives also room for all specialists, including Nurses, we are working with to show the role Paediatric Cardiology has to play in managing our patients throughout the life cycle.
Innsbruck, the wonderful place in the Alps is not only a very scenic but cultural and historical site too. As host of two Olympic Winter Games, Innsbruck has experience in hosting international conferences and with all the facilities we hope to meet AEPC’s and your personal needs and standards making this a memorable Annual Meeting.
Congress President
5
COMMITTEESLocal Organising CommitteeJörg-Ingolf SteinDaniela BaumgartnerRalf GeigerUlrich Schweigmann
Department of PaediatricsDivision of Paediatrics IIICardiology, Pulmology, Allergology, Cystic FibrosisInnsbruck Medical UniversityAnichstraße 35, A-6020 Innsbruck, AustriaT: +43 (0)512 504 23481 F: +43 (0)512 504 23484
Scientifi c Committee - AEPC CouncilAndré Bozio - PresidentShakeel Qureshi - President ElectEero Jokinen - Secretary GeneralJoseph de Giovanni - Scientifi c SecretaryJörg-Ingolf Stein - TreasurerBohdan Maruszewski - CouncillorKonrad Brockmeier - CouncillorKatharina Hanseus - CouncillorGeorgia Sarquella Brugada - Junior Councillor Japanese Society of Pediatric Cardiology and Cardiac SurgeryToshio Nakanishi - PresidentHideaki Kado - Vice PresidentBen Saji - Secretary GeneralShunichi Ogawa - Scientifi c Committee ChairKoichiro Niwa - Int. CommunicationKisaburo Sakamoto - Treasurer Makato Nakazawa - Past President
6
IMPORTANT ADDRESSESConference VenueCongress und Messe Innsbruck GmbHRennweg 3, A-6020 Innsbruck I: www.come-innsbruck.at
Congress Organisation, Hotel Reservation pco tyrol congressRennweg 3, 6020 InnsbruckT: +43-(0)512-575 600 F: +43-(0)512-575 607E: [email protected]: www.pco-tyrolcongress.at
Industrial Exhibition/ Sponsoringmed.ex Medizinische Ausstellungsgesellschaft mbHRennweg 3, A-6020 InnsbruckMag. Klaus EhrenmüllerT: +43-(0)512-5936 186, F: +43-(0)512-5936 189E: [email protected]: www.medex.co.at
7
GENERAL INFORMATIONRegistration desk at the Congress InnsbruckThe registration desk will be located on the ground fl oor of the Congress Innsbruck. Opening hours are as follows:
Wednesday, 26 May 07.30 – 18.00Thursday, 27 May 07:30 – 18:00Friday, 28 May 07:30 – 18:00Saturday, 29 May 08:00 – 13:00
On site registration fees
AEPC junior members e 250.00
AEPC members e 475.00
Non members e 575.00
Nurses, technicians e 250.00
On site registration fees for “Update” organised by the»Cardiac Dysrhythmias and Electrophysiology Working Group«
AEPC junior members included in reg. fee
AEPC members e 120,00
Non members e 140,00
Registration fees include• admission to scientifi c sessions and industrial exhibition• programme and abstract book• conference bag• welcome reception• coffee breaks• lunch breaks
Update CourseThe Update Course is scheduled on Wednesday, May 26th. Registration for the course has to be done separately. Access to Update course is not included in the regular registration fee. The Update Course is accredited by the European Board for Accredi-tation in Cardiology (EBAC) for 5 hours of External CME credits.
Certifi cate of attendanceAll registered delegates receive a certifi cate of attendance on site. The conference is accredited by the European Board for Accreditation in Cardiology (EBAC) for 21 hours of External CME credits. Certifi cates will only be handed out starting from Friday noon.
8
Industrial exhibitionAn industrial exhibition is held during the AEPC 2010 Annual Meeting in the Tirol and Kristall Foyer, located on the second fl oor of the conference venue.
Internet AccessUnlimited wireless LAN access is provided for all delegates within the congress venue for the use of own laptops as well as at internet corners.
Real time programmeDuring the meeting, the scheduled programme is shown in the internet in real time. For detailed information please visit the following website: www.aepc2010.at/pro-gramme.htm
Coffee Breaks, Lunch and refreshments Coffee and tea will be served during the offi cial coffee breaks. Lunch will be provided from a number of serving stations around the exhibition and poster area. In addi-tion, company sponsored lunch symposia will be held on Wednesday and Thursday. Outside these offi cial breaks, refreshments are available from cash bars located in the exhibition area.
Name badgesAll registered participants and exhibitors receive a name badge together with their registration documents. Please make sure to wear your badge at all times while at-tending the meeting, exhibition and social events.
City transportationThere is a good public transport system in Innsbruck and its surroundings. Most buses operate until midnight. Detailed information on bus schedules is available at your hotel or at the conference centre. Tickets can be pre-purchased from tobacco-nists or directly in the buses.
ParkingThere is an underground car park at the Congress Centre. Participants obtain tickets at reduced rates from the concierge. Please note that these reduced fares only apply to the Congress Garage and not to the adjacent CityGarage parking facilities.Street parking in the city is available but limited to 90 minutes (indicated by a blue line). Tickets have to be purchased from a blue parking meter, where the appropriate fees are indicated.
Liability and insuranceNeither the organisers, nor the congress secretariat or other suppliers accept liability for any injury, loss or damage, arising from accidents or other situations during, or as a consequence of the congress. Kindly check your personal insurance.
9
INFORMATION FOR AUTHORS AND CHAIRPERSONSInformation for speakersAll rooms are equipped with a data projector and a PC for Power-Point-Presentation. Please make sure to bring your presentation on a USB-Stick to the media check well in advance, two hours prior to the start of your session at the latest. Do not bring your laptop for the lecture. The media check is located in room “Serles” on the ground fl oor of the congress centre.In case your presentation contains videos, please make sure to pack them with a standard codec and make sure to copy all necessary fi les onto the server. Your pre-sentation will be uploaded to the lecture hall and started by an assistant.
In order to be able to keep the time schedule, please make sure not to exceed the allotted speaking time.
Poster presentationsPosters are displayed throughout the conference. The poster exhibition area is on the second fl oor of Congress Innsbruck. Posters should be mounted on May 26th and taken down on Saturday, May 29th. All posters which have not been removed by the authors at the end of the conference will be discarded!Please remember your poster number by which you will be able to identify your pos-ter board on site. Assistance and mounting material will be provided.
Information for poster presenters:A number of contributions have been selected for poster walks. Authors should be prepared to present their poster during the assigned session and to answer questions from the audience.
Best Poster AwardsThe Best Poster Awards will be given for the best poster presentations at the AEPC 2010 meeting. The decision will be made by a board of referees and the awards be presented during the AEPC Gala Dinner on May 28th! Best Poster Awards are kindly supported by W.L. Gore & Associates S.L.
10 Wed
nes
day
, M
ay 2
6,
20
10
Foye
rTi
rol
Brüs
sel
Aalb
org
New
Orle
ans
Max
imili
an
8:00
8:30
Upd
ate
on P
aedi
atric
Dy
srhy
thm
ias
and
Elec
trop
hysi
olog
y I
9:00
9:30
10:0
0Co
ffee
SAC
- M
eeti
ngNa
tion
al D
eleg
ate
Mee
ting
10:3
0U
pdat
e on
Pae
diat
ric
Dysr
hyth
mia
s an
d El
ectr
ophy
siol
ogy
II11
:00
11:3
0
12:0
0
Lunc
h12
:30
13:0
0
Codi
ng C
omm
itte
e M
eeti
ngPA
C -
Mee
ting
CHD
accr
edit
atio
n ex
am
13:3
0U
pdat
e on
Pae
diat
ric
Dysr
hyth
mia
s an
d El
ectr
ophy
siol
ogy
III
14:0
0
14:3
0
15:0
0
15:3
0
16:0
0
Open
ing
Cere
mon
y16
:30
17:0
0
17:3
0
18:0
0
Wel
com
e Re
cept
ion
18:3
0
19:0
0
19:3
0
20:0
0
PR
OG
RA
MM
E O
VER
VIE
W
11Wed
nes
day
, M
ay 2
6,
20
10
Foye
rTi
rol
Brüs
sel
Aalb
org
New
Orle
ans
Max
imili
an
8:00
8:30
Upd
ate
on P
aedi
atric
Dy
srhy
thm
ias
and
Elec
trop
hysi
olog
y I
9:00
9:30
10:0
0Co
ffee
SAC
- M
eeti
ngNa
tion
al D
eleg
ate
Mee
ting
10:3
0U
pdat
e on
Pae
diat
ric
Dysr
hyth
mia
s an
d El
ectr
ophy
siol
ogy
II11
:00
11:3
0
12:0
0
Lunc
h12
:30
13:0
0
Codi
ng C
omm
itte
e M
eeti
ngPA
C -
Mee
ting
CHD
accr
edit
atio
n ex
am
13:3
0U
pdat
e on
Pae
diat
ric
Dysr
hyth
mia
s an
d El
ectr
ophy
siol
ogy
III
14:0
0
14:3
0
15:0
0
15:3
0
16:0
0
Open
ing
Cere
mon
y16
:30
17:0
0
17:3
0
18:0
0
Wel
com
e Re
cept
ion
18:3
0
19:0
0
19:3
0
20:0
0
Thu
rsd
ay,
May
27
, 2
01
0Ti
rol
Brüs
sel
Inns
bruc
kFr
eibu
rgGr
enob
leAa
lbor
gNe
w O
rlean
sSt
raßb
urg
8:00
WG
Dysr
hyth
mia
/
Elec
trop
hysi
olog
yW
G Ca
rdia
c Im
ag-
ing
WG
Paed
iatr
ic
Inte
nsiv
e ca
reW
G Ca
rdio
vasc
u-la
r M
orph
olog
yW
G Ps
ycho
-so
cial
car
e8:
309:
00In
terc
ultu
ral
atti
tude
s to
war
ds
Qual
ity
of L
ife
9:30
10:0
010
:30
Coff
ee B
reak
, Ex
hibi
tion
and
Pos
ter
11:0
0W
G Fe
tal
card
iolo
gy -
HLH
SAb
stra
ct s
essi
on 1
: Ge
nera
l Car
diol
ogy
I
WG
Dysr
hyth
mia
s/El
ectr
ophy
siol
ogy-
Ab
lati
o11
:30
12:0
012
:30
Lunc
h Br
eak
„Han
ds o
n“ W
G Ca
rdio
vasc
ular
M
orph
olog
y I
13:0
0Lu
nch
Sym
posi
um:
3D I
mag
ing
(Sie
men
s)Lu
nch
Sym
posi
um
Juni
or M
embe
rs13
:30
14:0
0Jo
int
sess
ion
WGs
Fe
tal/
Dysr
hyth
mia
s an
d El
ectr
ophy
silo
gy
Abst
ract
ses
sion
3:
Surg
ery/
Inte
nsiv
e Ca
re
Abst
ract
ses
sion
2:
Imag
ing
„Han
ds o
n“ W
G Ca
rdio
vasc
ular
M
orph
olog
y II
14
:30
15:0
015
:30
Post
er W
alk
1 &
2,
Coff
ee B
reak
16:0
016
:30
WG
Paed
iatr
ic
card
iova
scul
ar
Inte
nsiv
e Ca
re
WG
Card
iova
scul
ar
Mor
phol
ogy
- PA
HAb
stra
ct s
essi
on 4
: GU
CH17
:00
17:3
018
:00
AEPC
Bus
ines
s M
eeti
ng18
:30
19:0
019
:30
20:0
0
12 Frid
ay,
May
28
, 2
01
0Ti
rol
Brüs
sel
Inns
bruc
kFr
eibu
rgGr
enob
leAa
lbor
gNe
w O
rlean
s
8:00
WG
BM:
Inte
rven
tion
al
Card
iolo
gy
WG
BM:
Feta
l Car
diol
ogy
WG
BM:
GUCH
Tas
k Fo
rce
WG
BM:
Gene
tics
and
Ba
sic
Scie
nce
WG
BM:
Cong
enit
al
Hea
rt S
urge
ryCo
ngen
ital
Hea
rt S
urge
ry8:
30
9:00
Inte
rcul
tura
l ap
proa
ch t
o he
art
repl
acem
ent
ther
apy
Abst
ract
ses
sion
5:
Gene
ral C
ardi
olog
y II
WG
Imag
ing
- St
ress
im
agin
g in
CH
D9:
3010
:00
10:3
0Co
ffee
Bre
ak,
Exhi
biti
on a
nd P
oste
r11
:00
Join
t se
ssio
n JS
PCCS
/AE
PC -
Hot
top
ics
Abst
ract
ses
sion
7:
Dysr
hyth
mia
s an
d El
ectr
ophy
siol
ogy
Abst
ract
ses
sion
6:
Feta
l car
diol
ogy
11:3
012
:00
12:3
0Lu
nch
Brea
k13
:00
Lunc
h Sy
mpo
sium
: PP
VI -
Mel
ody
valv
e (M
edtr
onic
)
Lunc
h Sy
mpo
sium
: Ad
vanc
ed A
SD (
AGA)
13:3
0
14:0
0Jo
int
sess
ion
WGs
Im
agin
g/In
terv
enti
onal
Abst
ract
ses
sion
8:
Basi
c Sc
ienc
e an
d Ge
neti
cs
WG
Psyc
hoso
cial
car
e/Nu
rses
- C
arin
g fo
r th
e w
hole
chi
ld14
:30
15:0
015
:30
Post
er W
alk
3 &
4,
Coff
ee B
reak
16:0
016
:30
Joi
nt s
essi
onW
Gs B
asic
Sci
ence
an
d Ge
neti
cs a
nd
GUCH
Abst
ract
ses
sion
9:
Int
erve
ntio
nal
Card
iolo
gy
WG
Psyc
hoso
cial
ca
re/N
urse
s -
inte
rpro
fess
iona
l ne
eds
for
lifel
ong
care
17:0
0
17:3
0
18:0
018
:30
19:0
0Ga
la D
inne
r at
the
Im
peria
l Pal
ace
Inns
bruc
k19
:30
20:0
0
PR
OG
RA
MM
E O
VER
VIE
W
13Satu
rday
, M
ay 2
9,
20
10
Tiro
lIn
nsbr
uck
8:00
8:30
9:00
Join
t se
ssio
n W
Gs S
urge
ry
and
Inte
rven
tion
al c
ardi
olog
yAb
stra
ct s
essi
on 1
0 En
d st
age
9:30
10:0
0
10:3
0Co
ffee
Bre
ak, Ex
hibi
tion
and
Pos
ter
11:0
0W
G In
terv
enti
onal
-
Succ
esse
s an
d fa
ilure
s in
the
ca
thla
bTa
sk f
orce
GU
CH11
:30
12:0
0
12:3
0Cl
osin
g se
ssio
n
13:0
0
13:3
0
14:0
0
14:3
0
15:0
0
15:3
0
16:0
0
16:3
0
17:0
0
17:3
0
14
ADMINISTRATIVE MEETINGSWednesday, May 26, 201010:00 - 13:00 National Delegates Meeting Hall New Orleans 10:00 - 13:00 SAC-Meeting Hall Aalborg 13:00 - 15:00 PAC-Meeting Hall New Orleans 13:00 - 15:00 Coding Committee Meeting Hall Aalborg 13:00 - 18:00 CHD accreditation exam Hall Maximilian
Thursday, May 27, 201008:00 – 09:00 WG Business Meeting Cardiac Imaging Hall Freiburg 08:00 – 09:00 WG Business Meeting Dysrhythmia/Electophysyiology Hall Innsbruck 08:00 – 09:00 WG Business Meeting Cardiovascular Morphology Hall Aalborg 08:00 – 09:00 WG Business Meeting Psychosocial Care Hall New Orleans 08:00 – 09:00 WG Business Meeting Intensive Care Hall Grenoble 12:45 – 13:45 Board Meeting CTY - Cardiology in the Young Hall New Orleans 18:00 – 20:00 AEPC Business Meeting Hall Tirol
Friday, May 28, 201008:00 – 09:00 WG Business Meeting Interventional Cardiology Hall Innsbruck 08:00 – 09:00 WG Business Meeting Fetal Cardiology Hall Freiburg 08:00 – 09:00 WG Business Meeting GUCH Task Force Hall Grenoble 08:00 – 09:00 WG Business Meeting Genetics and Basic Science Hall Aalborg 08:00 – 09:00 WG Business Meeting Congenital Heart Surgery Hall New Orleans
15
AGENDA AEPC BUSINESS MEETING INNSBRUCKHall Tirol May 27, 2010 - 18h - 20h
1. Welcome address of the President Prof. André Bozio
2. Obituary
3. Report of the President (A. Bozio)
4. Report of the Secretary-General (E. Jokinen)
5. Report of the Scientifi c Secretary (J. de Giovanni)
6. Report of the Treasurer (J.I. Stein)
7. News from the Working Groups Cardiac Dysrhythmias and Electrophysiology U. Bauersfeld
Fetal Cardiology M. Melander
Basic Genetics of Congenital Heart Defects I. Frohn-Mulder
Pediatric Cardiovascular Intensive Care E. Da Cruz
Cardiac Imaging E. Valsangiacomo Büchel
Interventional Cardiology G. Brzezinska-Rajszys
Cardiovascular Morphology A. Angelini
Congenital Heart Surgery B. Maruszewski
Psycho-Social care from fetus to adult F. Casey
GUCH Task Force A. Szatmári
8. Report from the Advisory Board / National Delegates (JP Pfammatter)
9. Introduction of New Members (E Jokinen)
10. Replacement of Council Member (E Jokinen)
11. Election of the Secretary-General-Elect (E Jokinen)
12. Future Meetings : 2011 Granada 2012 Istanbul 2013 London 2014 Helsinki
14. Handover of the presidency (A. Bozio)
15. Other businesses
16
SCIENTIFIC PROGRAMME
Wednesday, May 26, 2010
08:30-15:30 Update on Paediatric Dysrhythmias and Electrophysiology This programme is supported by unrestricted Educational Grants from
Boston Scientifi c and Medtronic AF Solutions. Hall Brüssel
08:30 Opening remarks Urs Bauersfeld
08:40-10:00 Session 1: Arrhythmias in children - clinical management issues Chair: Nico Blom (Leiden, NL), Urs Bauersfeld (Zurich, CH)
08:40 Incessant SVT and tachycardia induced cardiomyopathy Freek van den Heuvel 09:05 Management of Wollf-Parkinson-White syndrome Manfred Marx 09:30 Hereditary arrhythmia syndromes - an update Arthur A Wilde
10:00-10:20 Coffee Break supported by Hypo Tirol Bank
10:20-12:00 Session 2: AV block and cardiac pacing in children Chair: Juha-Matti Happonen (Helsinki, FIN),
Freek van den Heuvel (Groningen, NL)
10:20 Congenital AV block: etiology and management Eric Rosenthal
10:45 Cardiac pacing ion children: technical issues Eric Rosenthal
11:10 Echocardiac assessment of cardiac dyssynchrony Maren Tomaske
11:35 Cardiac resynchronisation in children and CHD patients Jan Janousek
17
12:00-13:15 Lunch Break
13:15-15:30 Session 3: Arrhythmias in patients with congenital heart disease
Chair: Jan Janousek (Prague, CZ), Eric Rosenthal (London, UK)
13:15 JET and other postoperative arrhythmias in the ICU Jean Pierre Pfammatter
13:40 Sudden death in congenital heart disease Juha-Matti Happonen
14:05 ICD therapy in children and CHD patients Nico Blom
14:30 Surgical management of atrial arrhythmias in Fontan patints Barbara Deal
15:00 Rhythm Quiz and closing remarks Juha-Matti Happonen, Nico Blom
16:00-18:00 Opening Ceremony Hall Tirol Chair: Andre Bozio (Lyon, F), Jörg-Ingolf Stein (Innsbruck, A)
Mannheimer Lecture - The fragility of ideas Philipp Bonhoeffer
18:00 – 20:00 Welcome Reception Exhibition Area – Kristall and Tirol Foyer
18
Thursday, May 27, 2010
O8:00 -09:00 WG Business Meetings 1. Cardiac Imaging (Hall Freiburg) 2. Cardiac Dysrhythmias and Electrophysiology (Hall Innsbruck) 3. Cardiovascular Morphology (Hall Aalborg) 4. Psychosocial care (Hall New Orleans) 5. Paediatric cardiovascular Intensive Care (Hall Grenoble)
09:00-10:30 Intercultural attitudes towards Quality of Life In cooperation with the Austrian Offi ce of the Network of Institu-
tions for Medical Ethics Education of the Unesco Chair of Bioethics Hall Tirol Chair: Gabriele Werner-Felmayer (Innsbruck, A)
Jörg-Ingolf Stein (Innsbruck, A)
09:00 Gross National Happiness – Quality of life – That’s what is all about
Karma Ura
09:30 Paradigm shift in Paediatric Cardiology Makoto Nakazawa
10:00 Fetal Cardiology – its role in respect to Outcome, Ethical implicants and Quality of Life
Lindsay Allan
10:30-11:00 Coffe Break, Posters, Exhibition Foyers
11:00-12:30 WG Fetal cardiology - HLHS - new aspects on fetal diagnosis and management
Hall Tirol Chair: Helena Gardiner (London, UK), Mats Mellander (Gothenborg, S)
11:00 Fetal diagnosis and prediction of univentricular circulation and variants with worse prognosis
Andrea Dragulescu
11:20 Effects on fetal cerebral circulation Christoph Berg
11:40 Hybrid or Norwood - enabling the choice and appropriate selection of cases
Owen Miller
19
12:00 Ethical aspects on prenatal diagnosis and counseling in fetal AS and HLHS: »Aggressive management of fetuses with emerging HLHS is the most ethical approach in the current era« - Pro Joanna Dangel, contra Alain Frasse
11:00-12:30 WG Dysrhythmias and Electrophysiology - Ablatio Hall Innsbruck Chair: Urs Bauersfeld, (Zurich, CH),
Juha-Matti Happonen (Helsinki, FIN)
11:00 Long term effects of catheter ablation on growing myocardium Phil Saul
11:20 Ventricular Tachycardia in children with structurally normal hearts, role of ablation
Thomas Kriebel
11:40 The role of cryoablation in paediatric patients Thomas Paul
12:00 Catheter ablation of arrhythmia in operated congenital heart disease
Joachim Hebe
11:00-12:30 Abstract Session 1: General Cardiology I Hall Brüssel Chair: Katharina Hanseus (Lund, S), Michael Hofbeck (Tübingen, D)
11:00 O1-1 Pre-operative assessment for Total Cavo-pulmonary Connection
in Hypoplastic Left Heart Syndrome with MRI alone: Evaluation of outcomes
Bellsham-Revell H., Witter T., Razavi R., Bell A.J.
11:12 O1-2 Total Anomalous Pulmonary Venous Drainage: Outcomes of Post-
Operative Pulmonary Venous Obstruction from a Multinational Population-Based Study
Seale A.N., Uemura H., Webber S.A., Partridge J., Roughton M., Ho S.Y., McCarthy K.P., Jones S., Shaughnessy L., Sunnegardh J., Hanseus K., Berggren H., Johansson S., Rigby M.L., Keeton B.R., Daubeney P.E.F.
20
11:24 O1-3 Length of pleural effusions after Fontan completion is prolon-
ged with extracardiac Fontan and Right ventricular morphology Stumper O., Stickley J., Parkes S., Anderson B., Jones T., Barron D.,
Brawn W.J.
11:36 O1-4 Congenital Heart Defects in Europe 2000-2005 Garne E., Loane M., Dolk H.
11:48 O1-5 Results of the PAN study: Congenital heart defects in newborns
in Germany - prevalence and association with demographic, genetic and peripartal parameters
Lindinger A., Schwedler G., Hense H.-W.
12:00 O1-6 SWEDCON – The Swedish Registry of Congenital Heart Disease Björkhem G., Thilén U.
12:12 O1-7 What is the optimal dose of clopidogrel in children with heart
disease? Naqvi N., Edwards S., Damda F., Maiya S., Jiggins M., Chubb H., Forrestor S., Slavik Z.
12:30-14:00 Lunch Break supported by Siemens AG
12:30-14:00 “Hands on” live demonstration by the WG Cardiovascular Morpholgy I Hall Strassburg Chair: Annalisa Angelini (Padua, I), Yen Ho (London, UK)
Segmental Analysis and TGA, ccTGA & DORV Adriana Gittenberger de Groot
13:00-14:00 Lunch Symposium Siemens AG – 3D Imaging in Pediatric Cardiology – Toy or Tool?
Hall Tirol Chair: Ludger Sieverding (Tübingen, D)
13:00 Instantaneous full volume echocardiography in paediatric cardiology Ulrich Schweigmann
21
13:20 The use of angiographic 3-D CT Imaging during catherization for congenital heart disease Sven Dittrich
13:40 3-D Imaging during Percutaneous Pulmonary Valve Implantation prevents possible Coronary Artery Compression
Andreas Eicken
13:00-14:00 Lunch Symposium - Junior Members Hall Freiburg Chair: Georgia Sarquella Brugada (Paris, F) Medical Education in Paediatric Cardiology Tara Barucha
14:00-15:30 “Hands on” live demonstration by the WG Cardiovascular Morphology II Hall Strassburg Chair: Adriana Gittenberger de Groot (Leiden, NL),
Annalisa Angelini (Padua, I)
HLHS, VSDs, Fallot Yen Ho
14:00-15:30 Joint session WGs Fetal Cardiology and Dysrhythmias and Elec-trophysiology – Diagnosis and Management of fetal dysrhythmia
Hall Tirol Chair: Nico Blom (Leiden, NL), Renate Oberhoffer (Munich, D)
14:00 Making a diagnosis of fetal tachycardia: practice and pitfalls Hana Jicínská
14:15 Fetal tachycardia: a review of therapeutic options and outcomes Pawel Wlasienko, Anita Hamela-Olkowska
14:30 Isolated fetal heart block: current management in Europe - results of the multicentre European study
Hakan Eliasson
14:45 Isolated fetal heart lock: current managment in North America - the Toronto experience
Edgar Jaeggi
15:00 Controversies in treatment of CHB - Round Table
22
14:00-15:30 Abstract session 2: Imaging – Educational Grant by TomTec Imaging Systems GmbH
Hall Innsbruck Chair: Eero Jokinen (Helsinki, FIN),
Wolfgang Radtke (Wilmington, USA)
14:00 The right ventricle in tetralogy of Fallot: do we benefi t from real-time 3-dimensional echocardiography?
Heleen van der Zwaan
14:25 O2-1 Assessment of ventricular function and dyssynchrony in
anatomic subtypes of hypoplastic left heart syndrome after Fontan surgery using 2D speckle tracking
Petko C., Hoffmann U., Möller P., Kramer H.-H., Uebing A.
14:37 O2-2 Present results after correction of Tetralogy of Fallot in Germany
– Prospective analysis of 407 patients for realistic expectations in the results of exercise testing and cardiac MRI
Sarikouch S., Dubowy K.O., Burkhardt B., Mir T.S., Hager A., Peters B., Kuehne T., Beerbaum P.
14:49 O2-3 Pulmonary vascular resistance and systolic-diastolic ventricu-
lar function in Fontan patients at rest and during dobutamine stress
Kuehne T., Schmitt B., Steendijk P., Ovroutski S., Lunze K., Rahmanzadeh P., Maarouf N., Ewert P., Berger F.
15:01 O2-4 Experience with dobutamine stress echocardiography in the
pediatric population Joly H., Ducreux C., Henaine R., Sassolas F., Gouton M., Ninet J.,
Bozio A., Di Filippo S.
15:13 O2-5 Dobutamine Stress MR in Tetralogy of Fallot with severe pulmo-
nary regurgitation: Is RV-ESV response important? Parish V., Valverde I., Head C., Greil G., Rosenthal E., Qureshi S.A.,
Schaeffter T., Sarikouch S., Razavi R., Beerbaum P.
23
14:00-15:30 Abstract seesion 3: Surgery/Intensive Care Hall Brüssel Chair: Boulos Asfour (St. Augustin, D), Fatima Pinto (Lisbon, P)
14:00 Double switch operation Toshikatsu Yagihara
14:20 O3-1 Rotation of the truncus arteriosus – established surgical
procedure Ovroutski S., Miera O., Peters B., Ewert P., Berger F., Hetzer R.,
Hübler M.
14:32 O3-2 Bicuspidation of cryopreserved pulmonary homografts for recon-
struction of the right ventricular outfl ow tract Rega F., Jacobs S., Allaeys M., Jashari R., Daenen W., Gorenfl o M.,
Heying R., Eyskens B., Gewillig M., Meyns B.
14:44 O3-3 Results of a tissue engineered pulmonary valve in humans Rickers C., Entenmann A., Fischer G., Scheewe J., Scheid M.,
Braesen J., Voges I., Hart C., Kramer H.-H.
14:56 O3-4 Early survival in 264 patients following the Sano-modifi ed
Norwood procedure: infl uence of morphologic subtype Murtuza B., Wall D., Stickley J., Jones T.J., Barron D.J., Brawn W.J.
15:08 O3-5 Small Right Ventricle to Pulmonary Artery Conduits in Infancy Anderson B.W., Stumper O., Desai T., Stickley J., Jones T., Brawn W.,
Barron D.
15:30-16:30 Coffee Break supported by Milupa GmbH
15:30-16:30 Poster Walk 1 Künstler Foyer Chair: Jochen Weil (Hamburg, D), Jan Sunnegard (Gothenburg, S)
PW1-1 Cardiac Magnetic Resonance Imaging (CMRI) for non-invasive assessment of cardiovascular disease in the follow-up of Kawasaki disease
Kuipers I.M., Tacke C.E.A., Groenink M., Spijkerboer A.M., Kuijpers T.W.
24
PW1-2 Cardiac synchrony and function with chronic single-site left versus right ventricular epicardial pacing in paediatric patients after patch closure of ventricular septal defects
Tomaske M., Janousek J., Kubus P., Gebauer R.A.
PW1-3 Echocardiographic Evaluation of Left Ventricular Function over time and Risk Factors for Coronary Artery Lesion Formation in Incomplete Kawasaki Patients
Rhie S.K., Kang S.J.
PW1-4 Reduced left ventricular twist and global strain in patients after tetralogy of Fallot correction is related to right ventricular dysfunction: evidence for detrimental role of apical ventricular-ventricular interaction on left ventricular function
van der Hulst A.E., Delgado V., Holman E.R., Kroft L.J.M., de Roos A., Hazekamp M.G., Blom N.A., Bax J.J, Roest A.A.W.
PW1-5 Flow-sensitive four-dimensional (4D) magnetic resonance ima-ging for fast, multiple and accurate blood fl ow quantifi cation in patients with congenital heart disease
Nordmeyer S., Khasheei A., Riesenkampff E., Schmitt B., Messroghli D., Berger F., Kuehne T.
PW1-6 Dobutamine Stress-Magnetic Resonance Imaging in repaired Tetralogy of Fallot: Agreement of fl ow- versus volumetric-derived parameters of cardiac function
Valverde I., Parish V., Razavi R., Greil G., Head C., Qureshi S., Rosenthal E., Schaeffter T., Beerbaum P.
PW1-7 Interpretation of left ventricular diastolic dysfunction in children: Time for a new approach?
Friedberg M.K., Dragulescu A., Mertens L.
PW1-8 Higher Dose Dobutamine Stress MR In Tetralogy Of Fallot: Right Ventricular End Systolic Volume (RV-ESV) Is A Reliable Para-meter Of Systolic RV Function With Low Observer Variance
Parish V., Valverde I., Head C., Rosenthal E., Qureshi S., Greil G., Schaeffter T., Razavi R., Beerbaum P.
PW1-9 New insights in patients with aortic coarctation - visualization of fl ow-sensitive data from 4-dimensional MRI
Fischer M., Unterhinninghofen R., Ley-Zaporozhan J., Rengier F., Eichhorn J., Ley S.
25
PW1-10 Cardiac-comitted human embryonic stem cells as a therapeutic agent in congenital right ventricular dysfunction?
Lambert V., Capderou A., Lebret E., Rücker-Martin C., Gouadon E., Raymond N., Dinanian S.,Stos B., Pucéat M., Serraf A., Renaud J.F.
PW1-11 Is early tissue Doppler diastolic velocity (E’) useful to diagnose left ventricular diastolic dysfunction in children with cardiomyopathy?
Friedberg M.K., Dragulescu A., Mertens L.
PW1-12 Quantifi cation of regional left and right ventricular longitudinal function by 2D speckle tracking imaging in children after atrioventricular node slow pathway ablation
Sileikiene R., Vaskelyte J., Baksiene D., Mizariene V., Ziuteliene A., Jurkevicius R.
15:30-16:30 Poster Walk 2 Künstler Foyer Chair: François Godart (Lille, F), Gerald Tulzer (Linz, A)
PW2-1 Long-term left ventricular adaptation in children and adolescent athletes
Bartkeviciene A., Baksiene D., Raskauskiene N., Vainoras A., Brozaitiene J.
PW2-2 Brain Natriuretic Peptide response in functionally univentricular heart: from fi rst days of life to the follow-up of total cavo-pulmonary connection
Cantinotti M., Margaryan R., Arcieri L., Maizza A., Storti S., Prontera C., Luisi S., Bernabei M., Crocetti M., Assanta N., Murzi B.
PW2-4 BMPR2 mutation in Children with Pulmonary Arterial Hypertension associate with Congenital Heart Disease
Limsuwan A., Wattanasirichaigoon D.
PW2-5 The usefulness of scintigraphy with 99 m Tc-Anti-Granulocyte antibody for diagnosis and follow-up in children with myocarditis
Ziolkowska L., Kawalec W., Biernatowicz M., Swiatek-Rawa E., Kaminska A., Turska-Kmiec A., Boruc A., Czarnowska E., Brzezinska-Rajszys G., Raszek M.
PW2-6 Effect of dexamethasone on the infl ammatory response and myocardial protection during and after arterial switch operation in neonates: A double blind randomized controlled study
Heying R., Wehage E., Tassani P., Haas F., Hess J., Seghaye M.C.
26
PW2-7 Rotational Mechanics and Left Ventricular Propagation Velocity Elucidate Mechanisms of Left Ventricular Diastolic Dysfunction in Children with Dilated Cardiomyopathy
Dillenburg R., Mertens L., Friedberg M.
PW2-8 Assessment of myocardial performance index in fetuses with supraventricular tachycardia successfully treated in utero
Dangel J.H., Hamela-Olkowska A.
PW2-9 Prevalence of anemia in children with congestive heart failure Mueller G.C., Schlueter E.L., Arndt F., Banhidai M.,
Dodge-Khatami A., Weil J., Mir T.S.
PW2-10 Quality of Life and Its Determinants in Parents of Children, Adolescents, and Young Adults with Congenital Heart Disease
Hua Y.C., Chen C.A.
PW2-11 Integrated analysis of atrio-ventricular interaction in tetralogy of Fallot
Riesenkampff E., Mengelkamp L., Mueller M., Kropf S., Abdul-Khaliq H., Sarikouch S., Beerbaum P., Hetzer R., Steendijk P., Berger F., Kuehne T.
PW2-12 Fibroblasts support functional integration of purifi ed embryonic stem cell-derived cardiomyocytes in avital myocardial tis-sue
Khalil M., Xi J., Spitkovsky D., Hannes T., Pfannkuche K., Bloch W., Saric T., Brockmeier K., Hescheler J., Pillekamp F.
16:30-18:00 WG Cardiovascular Morphology - Update on pulmonary arterial hypertension
Hall Brüssel Chair: Ralf Geiger (Innsbruck, A), Annalisa Angelini (Padua, I)
16:30 Pathobiology of pulmonary hypertension Annalisa Angelini
16:50 Lung and heart protection in experimental acute pulmonary hypertension
Ralph Geiger
17:05 Congenital heart diseases leading to pulmonary hypertension Yen Ho
27
17:20 Evaluation and current medical treatment Tsutomu Sajii
17:40 New therapeutic approaches: is there a place for reversibility of the lesions?
Michael Gatzoulis
16:30-18:00 WG Paediatric cardiovascular Intensive Care – So small and yet so big: important details of cardiac ICU patients
Hall Tirol Chair: Evelyn Lechner (Linz, A), Brigitte Stiller (Freiburg, D)
16:30 Infusion Management: a high-risk daily therapy and: how can we reduce SIRS?
Michael Sasse
16:55 Strategies to prevent or decrease blood transfusion in the ICU Thilo Fleck
17:15 Cardiac Index in babies with the new ultrasound dilutuion technique Valeria Perez de Sa
17:25 Mistakes to learn from Sylvie di Filippo, Valeria Perez de Sa
16:30-18:00 Abstract session 4: GUCH Hall Innsbruck Chair: Bo Lundell (Stockholm, S), Aris Lacis (Riga, LV)
16:30 O4-1 Vascular remodeling in adults after coarctation repair - impact
of descending aorta stenosis and age at surgery Trojnarska O., Szczepaniak-Chichel L., Mizia-Stec K., Gabriel M.,
Bartczak A., Grajek S., Tykarski A., Gasior Z. 16:42 O4-2 Male gender, cyanosis, high NYHA score, chromosomal abnorma-
lities and a systemic right ventricle are independent risk factors for cardiac operations of congenital heart defects in adulthood: A retrospective study on 530 patients
Vogt M., Hörer J., Otto D., Grünewald S., Schreiber Ch., Kaemmerer H., Hess J.
28
16:54 O4-3 Quality of life of adults after total cavopulmonary anastomosis Gouton M., Soufi A., Bozio A., Ninet J., Henaine R., Bernard Y.,
Ducreux C., Sassolas F., Di Filippo S.
17:06 O4-4 Stenting of the lateral Tunnel in Fontan patients – does size
matter in GUCH-Patients? Haas N.A., Beck C., Laser T.K., Dubowy O., Kececioglu D., Blanz U.,
Sandica E.
17:18 O4-5 Neurodevelopmental outcome in children and adolescents with
functional single ventricle after total cavopulmonary connection (TCPC)
Vahsen N., Bröder A., Toussaint-Götz N., Asfour B., Schneider M.
17:30 O4-6 Recurrence of congenital heart disease in offsprings of
mothers with congenital heart disease screened prenatally by echocardiography
Fesslova V., Brankovic J., Piazza L., Villa L., Meli V.
17:42 O4-7 Role of electrophysiological study after surgical pulmonary
valve replacement and right ventricular remodelling in GUCH patients with pulmonary regurgitation and aneurysmal RVOT dilatation
Tavera M.C., Foresti S., Lupo P.P., Ali H., De Ambroggi G., Pittalis M., Giamberti A., Chessa M., Negura D., Micheletti A., Carminati M., Cappato R.
18:00-20:00 AEPC Business Meeting Hall Tirol
29
Friday, May 28, 2010
O8:00 -09:00 WG Business Meetings 6. Interventional Cardiology (Hall Innsbruck) 7. Fetal Cardiology (Hall Freiburg) 8. GUCH Task force (Hall Grenoble) 9. Genetics and Basic Science (Hall Aalborg) 10. Congenital Heart Surgery (Hall New Orleans)
09:00-10:30 Intercultural approach to heart replacement therapy Hall Tirol Chair: Ann Karimova (London, UK), Brigitte Stiller (Freiburg, D)
09:00 Children’s rights in medicine Claudia Wiesemann
09:30 Berlin heart®: The London experience Ann Karimova
09:50 Case report, Berlin heart® experience Brigitte Stiller
10:00 Case report Ulrich Schweigmann
09:00-10:30 WG Imaging - Stress imaging in CHD Hall Innsbruck Chair: Ornella Milanesi (Padua, I), John Simpson (London, UK)
09:00 Coronary artery disease and CHD - when is stress assessment indicated? Sandra Giusti
09:20 Stress test and quality of life in long-term after Kawasaki Masahiro Ishii
09:50 Stress-echocardiography: when and how to perform Jan Marek
10:10 MRI stress imaging: when and how to perform Willem A Helbing
30
09:00-10:30 Abstract session 5: General Cardiology II Hall Brüssel Chair: Gudrun Bjoerkhem (Lund, S), John Hess (Munich, D)
09:00 O5-1 Relationship of Aortic Pulse Wave Velocity and Baroreceptor
Sensitivity to Blood Pressure Control in Patients with Repaired Coarctation of the Aorta
Kenny D., Polson J.W., Martin R.P., Cockcroft J.R., Wilson D.G., Caputo M., Paton J.F.R., Wolf A.R.
09:12 O5-2 Ventricular pressure-volume loops obtained by three
dimensional echocardiography and mini pressure wire Herberg U., Bernhardt C., Breuer T., Doll U., Knies R.,
Schirrmeister J., Vlajnic D., Breuer J.
09:24 O5-3 Exercise Stress Echocardiography is a safe and effi cient method
to detect Coronary Allograft Vasculopathy in Pediatric Heart Transplant Recipients - An Evaluation in comparison to Myocardial Perfusion SPECT with 99MTC-MIBI
Lunze F.I., Gauvreau K., Bergersen L., Geva T., Colan S.D., Blume E.D., Chen M.H.
09:36 O5-4 Results of cardiac surgery during neonatal period – focus on
morbidity, psychomotor aspects and quality of life Wolf N., Woerner C., Schulze J., Henjes S., Kostelka M., Janousek J.,
Dähnert I.
09:48 O5-5 Hypothermia during repair of ventricular septal defects (VSD)
in infants prolongs postoperative mechanical ventilation and inotropic support
Fedarava K., Schmitt K., Hübler M., Berger F., Miera O., Hetzer R.
10:00 O5-6 Long- and midterm results of the Growth Stent for the transca-
theter treatment of aortic coarctation in infants Ewert P., Schubert S., Yilmaz S., Peters B., Miera O., Ovroutski S.,
Nagdyman N., Berger F.
31
10:12 O5-7 Prognosis of non-compaction cardiomyopathy in the pediatric
population Veyrier M., Teyssier G., Henaine R., Sassolas F., Ducreux C., Gouton
M., Ninet J., Bozio A., Di Filippo S.
10:30-11:00 Coffee Break supported by St. Jude Medical 11:00-12:30 Joint session JSPCCS/AEPC - Hot topics Hall Tirol Chair: Andre Bozio (Lyon, F), Makoto Nakazawa (Tokyo, J)
11:00 New insights in heart development: the role of the second heart fi eld
Adriana Gittenberger De Groote 11:30 Clinical results of tissue engineered graft implantation in
congenital heart surgery Toshiharu Shinoka
11:50 New techniques in congenital cardiac surgery Shunji Sano
12:10 Clinical features and genetic background of left ventricular non-compaction
Fukiko Ichida
11:00-12:30 Abstract session 6: Fetal Cardiology Hall Innsbruck Chair: Vlasta Fesslova (Milano, I), Klaus Schmidt (Düsseldorf, D)
11:00 O6-1 Impact of antenatal diagnosis on outcomes of neonates with
coarctation of the aorta Di Filippo S., Abid D., Henaine R., Sassolas F., Ducreux C., Ninet J.,
Bozio A.
11:12 O6-2 Impact of Prenatal Diagnosis on Outcome of Pulmonary Atresia
with Intact Ventricular Septum Tuo G., Serafi no M., Volpe P., Zannini L., Petrucci L., Calevo M.G.,
Marasini M.
32
11:24 O6-3 3D reconstruction of the fi rst and early second trimester human
fetal heart Gardiner H., Matsui H., Mohun T., Ho S.Y.
11:36 O6-4 Prolongation of the Atrio-Ventricular Conduction in Fetuses
Exposed to Maternal Anti-Ro/SSA Antibodies does not Predict Progressive Heart Block
Jaeggi E., Silverman E.D., Golding F., Weber R.
11:48 O6-5 Impact of prenatal diagnosis on outcome of univentricular heart
disease Stiasny B., Fasnacht M., Prêtre R., Bauersfeld U., Valsangiacomo
Buechel E.R.
12:00 O6-6 Cardiac function between 11 and 35 weeks‘ gestation in trisomy
21 fetuses Clur S.A., Ottenkamp J., Bilardo C.M.
12:12 O6-7 Prenatal brain pathology in congenital heart disease - does
oxygen saturation of cerebral blood infl uence its occurrence? Mlczoch E., Brugger P., Hanslik A.,Ulm B., Salzer-Muhar U.,
Prayer D.
11:00-12:30 Abstract session 7: Dysrhythmias and Electrophysiology Hall Brüssel Chair: Jan Janousek (Prague, CZ),
Florian Hintringer (Innsbruck, A)
11:00 O7-1 Epicardial ablation of ventricular tachycardia in arrhythmogenic
right ventricular cardiomyopathy in children Pokushalov E., Romanov A., Artemenko S., Shugaev., Turov A., Shirokova N.
11:12 O7-2 Arrhythmia in patients older than 40 years undergoing
transcatheter closure of atrial septal defect Wang J.K., Wu M.H., Lin F.Y., Lin J.L., Tsai S.K.
33
11:24 O7-3 Non-fl uoroscopic Navigation for Accessory Pathway Ablation
in Pediatric and Young Adult Congenital Patients: Impact of Accessory Pathway Location
Papagiannis J., Avramidis D., Kazantzidis S., Kovra S., Alexopoulos C., Kirvassilis G.
11:36 O7-4 Acute and Long-Term Outcome after Catheter Ablation of Atrial
Tachycardia in post- Fontan Patients Hessling G., Wu J., Pfl aumer A., Hoppmann P., Estner H., Jilek C.,
Deisenhofer I., Hess J.
11:48 O7-5 LV Pacing Preserves Ventricular Synchrony and Function in Child-
ren with AV Block and Structurally Normal Heart as Compared to RV Pacing Sites: A Multi-Center Study
Janousek J., van Geldorp I.E., Prinzen F.W., Vanagt W., Delhaas T., Elders J., Früh A., Kubus P., Tomaske M., Ganame J., Nagel B., Papagiannis J., Wren C., Nürnberg J.-H., Gebauer R.A.
12:00 O7-6 Massive septal hypertrophy as a risk factor for malignant cardiac
arrhythmias in children with hypertrophic cardiomyopathy Boon G.B., Bökenkamp R., Blank A.C., Frohn-Mulder I.M.E.,
Delhaas T., Wolterbeek R., Kuipers I.M., Rammeloo L.A.J., Reimer A., Blom N.A.
12:30-14:00 Lunch Break supported by AGA Medical Corporation
13:00-14:00 Lunch symposium AGA Medical Corporation – Advanced ASD Closure Featuring the AMPLATZER Septal Occluder
Hall Innsbruck
13:00 A Review of My Complex ASD Cases Mario Carminati 13:25 ASD Tips & Tricks: Greatest Challenges for Implanting MDs Christian Jux 13:50 Question and Answer Session Mario Carminati, Christan Jux
34
13:00-14:00 Lunch symposium MEDTRONIC – PPVI – Melody® valve Hall Tirol
13:00 Percutaneous Pulmonary valve replacement using the Melody-valve – European results
Marc Gewillig
13:20 PPVI with the Melody® valve - Berlin approach with a specifi c vocus on diffi cult cases
Felix Berger
13:35 Special cases in the use of transcatheter pulmonary valve replacement
Jörg Ingolf Stein 14:00-15:30 Joint session WGs Imaging/Interventional Cardiology
Educational Grant by Philips Healthcare Hall Tirol Chair: Emanuela Vasangiacomo-Buechel (Zurich, CH),
Grazyna Brzezynska-Rajszys (Warsaw, PL)
14:00 MRI for planning catheter guided and surgical interventions Lars Grosse-Wortmann
14:20 Usefulness of 3D echocardiography before interventions on the left ventricular outfl owtract and aortic valve
Mark Friedberg
14:40 Micro-TEE in neonatal surgery John Simpson
15:00 Performing ASD closure without radiation in children: pro Ingo Daehnert, contra Shakeel Qureshi
14:00-15:30 WG Psychosocial care / Nurses programme – Caring for the whole child Hall Innsbruck Chair: Ulrike Salzer (Vienna, A), Ewa-Lena Bratt (Gothenburg, S)
14:00 Treating the whole child Frank Casey
14:20 Improving Behaviour and Educational Outcomes for Children with CHD
Sara O’Curry
14:40 Lifestyle Choices for Adolescents with CHD Katya de Groote
35
15:00 Experienced health state in adults with congenital heart disease – an analysis from the swedish GUCH-registry Malin Berghammer 14:00-15:30 Abstract session 8: Basic Science and Genetics Hall Brüssel Chair: Daniel de Wolf (Ghent, B), Patrice Bouvagnet (Lyon, F)
14:00 O8-1 Experimental development of a polydioxanone electrospun
tissue-engineered valved patch as a new tool for repair of the right ventricular outfl ow tract in congenital heart diseases
Kalfa D., Bel A., Chen-Tournoux A., Della Martina A., Rochereau P., Coz C., Bellamy V., Bensalah M., Mousseaux E., Bruneval P., Larghero J., Menasché Ph.
14:12 O8-2 Development of major aorto-pulmonary collateral arteries in
VEGF120 isoform mouse embryos with Tetralogy of Fallot Rammeloo L.A.J., Wisse L.J., DeRuiter M.C.,
Gittenberger-de Groot A.C.
14:24 O8-3 Right ventricular adaptation to pressure and volume load in
mice Bartelds B., Borgdorff M.A., Smit-van Oosten A., Takens J.,
Nederhoff M., van Gilst W.H., de Windt L.J., Berger R.M.
14:36 O8-4 Functional role of TASK-1 in the heart-studies in TASK-1
defi cient mice Donner B.C., Schullenberg M., Geduldig N., Decking U., Zacharowski K., Wisden W., Schmidt K.G.
14:48 O8-5 Spontaneous differentiation of embryonic stem cells leads to
functionally diversity of cardiac myocytes Hannes T., Halbach M., Wolff M., Pfannkuche K., Doss M.X.,
Sachinidis A., Hescheler J., Brockmeier K., Pillekamp F., Khalil M.
15:00 O8-6 Mutations in TRPM4 cause autosomal dominant isolated cardiac
conduction disease Bouvagnet P., Lui H., El Zein L., Bozio A., Mégarbané A., Blaysat G.,
Vilain E.
36
15 :12 O8-7 Ductal Stenting: Histopathology and Immunohistochemistry in
24 specimen Sigler M., Foth R., Quentin T., Schneider M., Kriebel T., Paul T.,
Michel-Behnke I.
15:30-16:30 Coffee Break supported by Actiopharm GmbH
15:30-16:30 Poster Walk 3 Künstler Foyer Chair: Alan Magee (London, UK), Margreet Bink-Boelk
(Groningen, NL)
PW3-1 Isolated Coarctation of the Aorta: experience in 100 consecutive patients
Ferreira Martins J.D., Costa G., Gouveia S., Paramés F., Freitas I., Trigo C., Fragata J., Pinto F.
PW3-2 Catheter Ablations in Children with Ventricular Tachycardia Pokushalov E., Romanov A., Artemenko S., Shugaev P., Turov A.,
Shirokova N.
PW3-3 Transeptal access to the left atrium following atrial septal device closure – feasibility and force needed with 3 different permanent and one absorbable closure device
Jux C., Kroll M., Steinmetz M., Michaelis I., Quentin T.
PW3-4 Simplifi ed 3-lead ECG as screening tool for LQT syndrome in children
Germanakis I., Androutsopoulou G., Perakaki R., Kakouri P., Kalmanti M.
PW3-5 The Importance of the Level of Maternal Anti-Ro/SSA Antibodies as a Prognostic Marker of the Development of Cardiac Neonatal Lupus Erythematosus: A Prospective Study of 186 Antibody-Exposed Fetuses and Infants
Jaeggi E., Laskin C., Hamilton R.M., Kingdom J., Silverman E.
PW3-6 Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children – the HEARTCAT study
Hanslik A., Kitzmüller E., Mlekusch W., Salzer-Muhar U., Michel-Behnke I., Male C.
PW3-7 NT-pro-brain natriuretic peptide (N-BNP) refl ects strongly left ventricular volume load before and after PDA closure in children and adolescents
Mueller G.C., Mir T.S., Arndt F., Samson-Himmelstjerna P., Dodge-Khatami A., Weil J.
37
PW3-8 Complications after pulmonary artery stenting in patients with hypoplastic left heart syndrome (HLHS) – what to be afraid of
Moszura T., Mazurek-Kula A., Dryżek P., Góreczny S., Moll J.A., Moll J.J., Sysa A.
PW3-9 Diagnostic and interventional percutaneous catheterization in the early postoperative period (≤30 days) after congenital heart surgery in children – a single-centre experience
Kretschmar O., Balmer C., Prêtre R., Dave H., Knirsch W.
PW3-10 First experience with the epicardial application of a transvenous 4.1 Fr lumenless pacemaker lead in patients with congenital heart disease
Peters B., Miera O., Ewert P., Hacke P., Alexi-Meskishvili V., Stamm C., Huebler M., Hetzer R., Berger F.
PW3-11 Long-term survival after paediatric cardiac surgery for congeni-tal heart defects
Sunnegardh J.T., Berggren H., Synnergren M.
PW3-12 Device Occlusion of Atrial Septal Defects (ASD) Without Balloon Sizing: Results of a Multicenter Registry
Radtke W.A.K., Holzer R., Owada C., Bandisode V.M., Lim S., Everett A.
15:30-16:30 Poster Walk 4 Künstler Foyer Chair: Marie Seghaye (Verviers, B), Andreas Gamillscheg (Graz, A)
PW4-1 Systolic right ventricular (RV) function in pediatric patients and adolescents with tetralogy of Fallot (TOF): Tricuspid annular plane systolic excursion (TAPSE), tricuspid annular peak systolic velocity (TAPSV), and RV ejection fraction (EF) in compariso
Koestenberger M., Nagel B., Stueger HP, Ravekes W., Everett AD., Heinzl B., Sorantin E., Cvirn G., Gamillscheg A.
PW4-2 Benefi cial effects of vasopressors in the treatment of experimental acute right ventricular failure induced by pulmonary artery constriction
Apitz C., Honjo O., Assad R., Humpl T., van Arsdell G., Redington A.N.
PW4-3 Longitudinal evaluation of hepatic function profi le following total cavopulmonary anastomosis
Kaulitz R., Haber P., Sieverding L., Ziemer G., Hofbeck M.
38
PW4-4 Patients with Repaired Tetralogy of Fallot Undergoing Pulmonary Valve Replacement - What Happens to Tricuspid Regurgitation?
Silva M., Inuzuka R., Li W., Tei E., Dimopoulos K., Gatzoulis M., Anjos R., Martins F.
PW4-5 Relationship between temporal sequence of right ventricular deformation pattern and right ventricular performance in patients with corrected tetralogy of Fallot
Roest A.A.W., Van der Hulst A.E., Delgado V.Holman E.R., De Roos A., Blom N.A., Bax J.J.
PW4-6 Innominate Vein-to-Common Atrium Fenestration at Fontan Completion: A Safe and Reproducible Option
von Samson P., Mir T.S., Arndt F., Philipp L., Schnegg C., Mueller G.C., Dodge-Khatami A.
PW4-7 En Bloc Rotation of the Truncus Arteriosus - Experience With a Complete Anatomic Repair of TGA/VSD/LVOTO or DORV/TGA/VSD/LVOTO
Mair R., Sames-Dolzer E., Innerhuber M., Steiner J., Gitter R., Tulzer G.
PW4-8 Extracardiac Fontan operation without cardiopulmonary bypass reduces complications and blood transfusions
Ovroutski S., Redlin M., Miera O., Peters B., Ewert P., Berger F., Hetzer R., Hübler M.
PW4-9 Dilated cardiomyopathy presenting in childhood: etiology, diag-nostic approach and clinical course
Gesuete V., Ragni L., Mariucci E., Oppido G., Formigari R., Prandstraller D., Gargiulo G., Picchio F.M.
PW4-10 Treatment of terminal heart failure and cardiogenic shock in 26 neonates and infants assisted by Berlin Heart Excor device
Miera O., Hübler M., Hetzer R., Berger F.
PW4-11 Fœtal double discordance: a series of 65 foetuses Bah G., Fermont L., Le Bidois J., Bonnet D.
PW4-12 Long-term Follow-up of Pulmonary Valve Replacement Following Repair of Tetralogy of Fallot
Ruzmetov M., Yurdakok O., Rodefeld M.D., Turrentine M.W., Brown J.W.
16:30-18:00 Marfan-Aortopthies - Joint session WGs Basic Science and Genetics and GUCH Taskforce Hall Tirol Chair: Ingrid Frohn-Mulder (Rotterdam, NL),
Harald Gabriel (Wien, A)
39
16:30 Marfan syndrome – diagnosis and treatment anno 2010 Julie de Backer
16:50 Aortopathy in ACHD Koichiro Niwa
17:10 Bicuspid Aortic valve – part of a syndrome?! Harald Kaemmerer
17:25 Adult coarctation – interventional issues Marc Gewillig
17:40 Surgical options for Aortopathies Thierry Carrel 16:30-18:00 WG Psychosocial care / Nurses programme – interprofessional needs for lifelong care Hall Innsbruck Chair: Frank Casey (Belfast, UK), Katya De Groote (Ghent, B)
16:30 Quality of Life – the parent’s view Anne Keatley-Clarke
16:50 Psychosocial consequences of diagnosis of hypertrophic cardiomyopathy in asymptomatic children through family screening
Ewa-Lena Bratt
17:10 11-1 Doctors don’t meet information needs of children and teenagers
with CHD Lesch W., Specht K., Lux A., Frey M., Bauer U.
17:25 Transition from paediatric to adult services for patients with congenital heart disease – an ongoing story
Eva Goossens 16:30-18:00 Abstract session 9: Interventional Cardiology Hall Brüssel Chair: Maarten Witsenburg (Rotterdam, NL)
Felix Berger (Berlin, D)16:30 O9-1 Fetal assessment of borderline small left ventricles: Can we
predict those with a need for a postnatal intervention? Weber R., Ayala-Arnez R., Atiyah M., Manlhiot C., McCrindle B.W.,
Hickey E.J., Jaeggi E.T, Nield L.E.
40
16:42 O9-2 In-utero intervention for fetal critical aortic stenosis:
indications, complications, results and outcome in 23 consecutive patients
Tulzer G., Arzt W., Veit I., Wertaschnigg D., Gitter R., Mair R.
16:54 O9-3 Patient selection for neonatal aortic balloon dilation. Who is
suited for biventricular circulation? Georgiev S., Eicken A., Balling G., Hess J.
17:06 O9-4 Percutaneous pulmonary valve implantation – Initial two center
experience Eicken A., Ewert P., Hager A., Peters B., Fratz S., Kuehne T., Hess J., Berger F.
17:18 O9-5 Stenting of aortic coarctation: Acute, intermediate, and long-
term results of a prospective multi-institutional registry - CON-GENITAL CARDIOVASCULAR INTERVENTIONAL STUDY CONSORTIUM (CCISC)
Holzer R.J., Qureshi S., Vincent J., Ghasemi A., Sievert H., Alday L.E., Peirone A., Gruenstein D.H., Forbes T., Weber H.S., Zeller T., Cheatham J.P., Slack M., Jarvois A.J., Hoyer M.H., Rome J.
17:30 O9-6 Stenting the arterial duct in neonates and infants with
congenital heart disease and duct-dependent pulmonary blood fl ow: a multicentre experience of 65 patients
Udink ten Cate F.E.A., Hamza H., Agha H., Kohli V., Emmel M., Qureshi S.A., Sreeram N., Rosenthal E.
17:42 O9-7 Mid-term follow-up of treatment of middle aortic syndrome in
children Brzezińska-Rajszys G., Zubrzycka M., Rewers B., Książyk J., Antoniewicz J., Turska-Kmiec A., Kościesza A., Ostoja-Chyżyńska A.
19:00 Gala Dinner At the Giant’s Hall of the Imperial Palace Innsbruck Best Poster Award Ceremony
41
Saturday, May 29, 2010
09:00-10:30 Joint session WGs Congenital Heart Surgery and Interventional Cardiology Hall Tirol Chair: Caroline Ovaert (Brussels, B),
Bohdan Maruszewski (Warsaw, PL)
Perimembranous VSD closure
09:00 Is device closure as good as surgery? Mario Carminati
09:15 PFM coil is less rigid than other devives Trong Phil Le
09:30 Leave perimembranous VSD to the surgeon Juan Comas
Pulmonary blood fl ow: early and late
09:45 Palliative pulmonary blood fl ow: Which options are available to the surgeon?
Pascal Vouhé
10:00 Palliative pulmonary blood fl ow: Neonatal duct stenting is better than surgical results
Shakeel Qureshi
10:15 Interventionalist can deal with small shunts to keep pace with growth of patients
Marc Gewillig
09:00-10:30 Abstract session 10: End stage - heart and lung disease Hall Innsbruck Chair: Heinrich Netz (Munich, D), Sally Ann Clur (Amsterdam, NL)
09:00 O10-1 Subcutaneous treprostinil in pediatric pulmonary arterial
hypertension Lévy M., Bajolle F., Szezepanski I., Bonnet D.
09:12 O10-2 Heart Transplantation in GUCH Population Vignati G., Ribera E., Bruschi G., Gagliardone M.P., Montorsi E.,
Aresta F., Paino R., Marianeschi S.M., Corato A., Frigerio M., Iorio F.S., Martinelli L., Santoro F.
SOR-
027-
09/1
/20.
10.2
009
3. Sehr gutes Sicherheitsprofi l – auch in Hochdosis 3
1. Kraftvolle LDL-C Senkung - 41 bis - 61 % 1
2. Endpunktdaten für Patienten mit ACS2a, Diabetes und KHK2b, Schlaganfall 2c
3 Merkmale sind für ein Statin ausschlaggebend.Sortis® bietet sie alle:
Ich kann mir keine Fehler leisten, denn das Schicksal anderer Menschen liegt in meinen Händen.
1 Sortis® Fachinformation Stand April 2007. 2a Cannon CP et al. N Engl J Med 2004; 350: 1495–1504., 2b Shepherd J et al. Diabetes Care 2006; 29: 1220–1226., 2c Amarenco P et al. N Engl J Med 2006; 355: 549–559. 3 Newman C et al. Am J Cardiol 2006; 97: 61–67.∆ Nur mehr dokumentationspfl ichtig. EKO-Regel: Bei nachgewiesener und dokumentierter Unverträglichkeit von Therapie-
alternativen aus dem Grünen Bereich (ATC-Code C10AA) und / oder wenn mit Therapiealternativen aus dem Grünen Bereich (ATC-Code C10AA) kein ausreichender Therapieerfolg (LDL-Zielwert 100 mg/dl) erzielt werden kann.
* Kassenpreis.
Sortis® 20 mg, 40 mg, 80 mg
in der hellgelben Box (RE2)∆!
3 Stärken zu einem Preis*!
Anzeige_Sortis_1xA4_hoch_200910.indd 1 22.10.09 15:56
43
09:24 O10-3 Transplant coronary artery disease is diagnosed later and is
more severe in pediatric heart recipients transplanted during infancy
Tissot C., Pietra B.A., Ivy D.D., Campbell D.N., Mitchell M.B., Miyamoto S.D.
09:36 O10-4 Survival and follow-up after cardiac transplantation for
congenital heart diseases Guillaume M.P., Timmermans T., Van Caeneghem O., Poncelet A.,
Gurné O., Carbonez K., Sluysmans T.
09:48 O10-5 More than ten years after heart transplantation in children Di Filippo S., Ducreux C., Henaine R., Boissonnat P., Sebbag L.,
Roussoulières A., Gouton M., Ninet J., Sassolas F., Bozio A.
10:00 O10-6 Specifi c vasodilator therapy in children with severe pulmonary
hypertension Alehan D., Şahin M., Yıldırım I., Karagöz T., Özer S, Özkutlu S.
10:12 O10-7 Neurocognitive defi cits in children requiring heart
transplantation in infancy Logeswaran T., Behnke-Hall, Bauer J., Akintürk H., Schranz D.,
Hahn A.
10:30-11:00 Coffee, Posters, Exhibition
11:00-12:30 Task force GUCH Hall Tirol Chair: Andre Bozio (Lille, F), Johannes Mair (Innsbruck, A)
11:00 Update on the ESC – Registry on Pregnancy in Congenital Hear Disease
Maarten Witsenburg
11:20 Compera – a prospective registry for PAH in Congenital Heart Disease
N.N.
11:35 International Network of Integrated Care (INIC) - one way for improving care in GUCH
K. Viktoria Stein
44
11:55 Tetralogy of Fallot – the fate of the pulmonary valve in the long term follow up
Andras Szatmari
11:00-12:30 WG Interventional – Successes and failures in the cathlab Hall Innsbruck Chair: Grazynska Brzezinska-Raizsys (Warsaw, PL),
Shakeel Qureshi (London, UK)
11:00 The pre-stenting technique for PVR Massimo Chessa
11:18 Acute severe hemorrhage in a 11 year old boy Ulrich Fakler
11:36 Complications during PPVI Andreas Eicken
11:54 Complete closure of perimembanous VSD with Amplatzer device. So why
Joseph de Giovanni
12:12 Interventional treatment of an interventional hole Maarten Witsenbrug
12:30-13:00 Closing session Hall Tirol Chair: Maria del Mar Rodriguez Vazgez del Rey (Granada, E),
Shakeel Qureshi (London, UK) 12:30 Surgery for congenital heart disease under the aspect of quality
of life Juan Comas
13:00 Farewell
45
LIST OF POSTERS 08:00-18:00 Posters Foyers, second fl oor
Arrhythmia/electrophysiology
P-1 Beta-blockers in the management of Congenital Long QT Syndrome Chockalingam P., Beckmann B.M., Clur S.A.B., van den Heuvel F., Kaab S., Blom N.A., Wilde A.A.M.
P-2 Dyssynchrony and ventricular function improve following catheter ablation of non-septal accessory pathways in childrenAbadir S., Fournier A., Dubuc M., Hugues N., Garceau P., Khairy P.
P-3 Sudden cardiac death: clinical evaluation of paediatric family members Tomaske M., Bauersfeld U.
P-4 On the origin of the Y111C/KCNQ1 founder mutation- a major cause of the Long QT Syndrome in Sweden Winbo A., Diamant U.B., Rydberg A., Jensen S.M., Stattin E.L.
P-5 Feasibility and reproducibility of conventional and color-coded tissue Doppler M-mode echocardiography in the assessment of septal-to-posterior wall motion delay in children and adolescents with right ventricular pacingUdink ten Cate F.E.A., Schmidt B.E., Wiesner N., Krüssell M.A., Sheta S.S., Breuer J., Trieschmann U., Brockmeier K., Sreeram N.
P-6 Can primary health care physicians interpret pediatric ECGs? Germanakis I., Nasikas D., Kalmanti M.
P-7 The Use of Transesophageal Electrophysiology Studies in Risk Assess Asymptomatic Ventricular Pre-Excitation
Snyder C., Desenna H., Rosenthal G.
P-8 Ventricular automatic capture (AC) is feasible and safe with unipolar epicardial leads in young patients with congenital heart
Kerst G., Gass M., Apitz C., Nagy Z., Ziemer G., Hofbeck M.
P-9 6-year experience with implanted cardioverter-de� brillators (ICD) in children in Department of Cardiology at Children’s Memorial Health Institute, Warsaw, Poland
Brzezinska-Paszke M., Bieganowska K., Miszczak-Knecht M., Rękawek J., Kaszuba A., Raszek M., Kawalec W., Birbach M.
P-10 Drug-refractory arrhythmias: radiofrequency ablation in neonates Brugada G., Bartrons J., Jimenez L., Rissech M., Carretero J., Prada F., Brugada J.
P-11 Impact of the individual circadian QTc variance for the validation of QT prolongation in children and adolescents
Fischer M., Ulmer H.E.
P-12 Diagnostic Accuracy of Brain Natriuretic Peptide for Congenital Heart Disease in the First Month of LifeCantinotti M., Arcieri L, Margaryan R, Maizza A, Storti S, Prontera C, Luisi S, Bernabei M, Crocetti M, Assanta N, Clerico A, Murzi B.
P-13 Percutaneous Transcatheter creation of an aortopulmonary shunt in an animal experimental model Sabi T., Schmitt B., Sigler M., Ovroutski S., Peters B., Miera O., Nagdyman N, Kuehne T., Berger F, Ewert P.
P-14 The Relation of Serum Levels of Matrix Metalloproteinases and Their Tissue Inhibitors with Cardiac Functions in Congenital Heart Diseases
Kilic Z., Ucar B., Erdogan P., Colak O., Demir T., Ertugrul T.
P-15 Endothelial pro-in� ammatory and pro-coagulant activity in a model of S. aureus endocarditis - impact of matrices used in tissue-engineered heart valves
Heying R., Wolf C., Beekhuizen H., Jockenhoevel S., Moelleken M.L., Hoylaerts M., Schmidt K.G., Schroten H.
P-16 Hypothermia decreases apoptosis after oxidative stress in cardiomyoctes Drescher C., Diestel A., Berger F., Schmitt K.
46
P-17 Deep hypothermia prevents in� ammation but leads to cellular stress in a coculture model of endothelial cells and macrophagesWollersheim S., Diestel A., Berger F., Schmitt K.
P-18 Fibroblasts facilitate the engraftment of embryonic stem cell-derived cardiomyocytes on three dimensional collagen I matricesAttia W., Pfannkuche K., Hescheler J., Brockmeier K.
P-19 Closure of Muscular Ventricular Septal Defects with a New Self Centering Patch System in a Large Animal ModelLang N., Mever A., Merkel E., Thalmann R., Lehner A., Freudenthal F., Vasilyev N., DelNido P., Netz H., Kozlik-Feldmann R.
P-20 Pulmonary artery banding as a novel therapeutic option for dilative cardiomyopathy (DCM): Thoughts about interaction between RV and LV in children with isolated RV pressure load due to pulmonary valve stenosis
Mueller G.C., Arndt F., Eman H.M., Schaefer A.-L., Mir T.S., Dodge-Khatami A., Weil J.
P-21 Ventricular assist devices: initial experience in a spanish center with the Berlin Heart EXCOR García-Guereta L., Aroca A., Villar MA., Menéndez J.,Carton A., Polo L., Oliva P., Cerro MJ.,Rodriguez E.,
Gutiérrez-Larraya F.,Villagrá
P-22 Eisenmenger Syndrome and Bosentan Therapy: a single centre experience Agnetti A., Tchana B., Carano N., Allegri V., Bo I., Dutto M., Quadrini I., Macchi C.,
Al-Obeyde M., Squarcia U.
P-23 15 year follow-up in renal function after pediatric heart transplantation in a single center Behnke-Hall K., Bauer J., Thul J., Logeswaran T., Horn M., Akintürk H., Valeske K., Schranz D.
P-24 Recurrence rate of cardiac disease in cases with family history of cardiomyopathy referred for fetal echocardiographyFesslova V., Brankovic J.,Piazza L., Villa L., Meli V.
P-25 Does Prenatal Anti-in� ammatory Treatment prevent from Late-Onset Dilated Cardiomyopathy (DCM) in Children with Immune-Mediated Congenital Complete AV Block (CAVB)? Results of a Retrospective Multicenter ExperienceHutter D.M., Hornberger L., Cuneo B., Fouron J.-C., Grady A., Friedberg M., Silverman N., Jaeggi E.
P-26 Prenatal prediction of early postnatal intervention in Tetralogy of Fallot Zidere V., Allan L.D.
P-27 Can mid-trimester Doppler � ow echocardiography predict an abnormal postnatal ECG? Sonesson S.-E., Bergman G., Wahren-Helenius M.
P-28 Gene Expression In Atrioventricular Junction From Fetal Hearts Hamilton M.R., Su B.B., Lung K., Capecchi M., Yan J.Y., Cui R., Liu L.
P-29 Prenatal diagnosis and outcome of fetuses with transposition of the great arteries (TGA) Rasiah S.V., Ewer A.K., Tonks A., Miller P., Wright J.G., Kilby M.D.
P-30 Diagnosis and outcome of prenatally diagnosed atrio-ventricular septal defect Kraska A., Własienko P., Kuran J., Dangel J.H.
P-31 Fetal critical aortic stenosis - with or without pharmacological transplacental treatment? Moszura T., Michalak K.W., Respondek-Liberska M., Janiak K., Ostrowska K., Sysa A.
General paediatric cardiology
P-32 An elevated value of a drug-induced lymphocyte stimulation test for immunoglobulin is one of the immunological abnormalities of Kawasaki disease
Nomura Y., Masuda K., Eguchi T., Morita Y., Arata M., Ueno K., Kawano Y.
P-33 Dynamics of Oxidative Stress in the Chronic Stage of Kawasaki Disease Yahata T., Suzuki C., Hamaoka A., Fujii M., Ozawa S., Hamaoka K.
P-34 The long-term outcome of cardiac sequelae with special reference to myocardial lesions and dysrhythmias in Kawasaki patients who reached adult
Yonesaka S., Takahashi T., Otani K., Jun S., Konno Y., Sato T., Kitagawa Y., Eto S., Ueda T., Sato A., Ichinose K., Kinjo M.
47
P-35 Tricuspid annular plane systolic excursion (TAPSE) in pediatric and adolescent patients with tetralogy of Fallot (TOF), patients with atrial septal defect (ASD), and age-matched normal subjects
Koestenberger M., Nagel B., Stueger HP., Ravekes W., Everrett A.D., Heinzl B., Sorantin E., Cvirn G., Gamillscheg A.
P-36 Alveolar To Arterial Oxygen Tension Di� erence Increases Due To Mild Impediment Of Pulmonary Circulation In Patients After Bidirectional Glenn Anastomosis
Hamamichi Y., Ishii R., Terashima Y., Kadota A., Kawazu Y., Inamura N., Kayatani F., Kawata H., Kishimoto H.
P-37 Moderate Hypoventilation Is Risk Factor For Residual Pulmonary Hypertension In Down Syndrome With Left-to-right Shunts Defects
Hamamichi Y., Ishii R., Terashima Y., Kadota A., Kawazu Y., Inamura N., Kayatani F., Kawata H., Kishimoto H.
P-38 Risk factors for postoperative subaortic stenosis: a serious long-term complication to detect early Kalfa D., Ghez O., Metras D., Kreitmann B.
P-39 Markers of endothelial dysfunction in youths with essential arterial hypertension Plotnikova I.V., Kovalev I.A., Suslova T.E., Churilova V.O., Bezlyak V.V.
P-40 Radiofrequency ablation in� uence on intracardiac hemodynamics in children with idiopathic ventricular premature beats
Chernushev A.A., Zavodovsky K.V., Kovalev I.A., Popov S.V., Lishmanov Yu.B.
P-41 Pharmacological test with sildena� l at pulmonary hypertension assessing in children with congenital heart diseasesYanulevich O.S., Ivanov S.N., Kovalev I.A., Krivoshchekov E.V.
P-42 Immune Globulin Therapy is Associated with Better Outcome of Infants and Children with Cardiomyopathy Induced Heart Failure - Results from centers with no pediatric heart transplantations Kampel L., Perles Z., El-Lahham N., Braun J., Rein A.J.J.T., Nir A.
P-43 Executive function and social cognition in school-aged children after neonatal corrective cardiac surgery for transposition of the great arteries
Calderon J., Bonnet D., Courtin C., Concordet S., Plumet M.H., Angeard N.
P-44 Quality of Life in Patients with Congenital Heart Disease Silva A.M., Vaz C., Areias M.E.G., Vieira D., Proença C., Viana V., Moura C., Areias J.C.
P-45 Six-minute walk distance in obese children and adolescents – e� ect of a weight reducing programme Geiger R., Rauchenzauner M., Willeit J., Rummel M., Högler W., Stübing K., Stein J.-I.
P-46 Anomalous Origin of the Left or Right Coronary Artery from the Pulmonary Artery (ALCAPA / ARCAPA): A 10-year single center experience
Flosdor® P., Riede F.T., Suchowerskyj P., Cho M., Kostelka M., Dähnert I.
P-47 Volatile substance abuse: Evaluation of QT Dispersion and sudden death risk in children with volatile substance addictionLevent E., Can S., Demir E, Yüncü Z, Özyürek A.R.
P-48 Croatian Study (2002-2007): Distribution of congenital heart defects and outcome analysis Malčić I., Dilber D.
P-49 Intrauterine Growth Restriction does not impair Cardiac Function and Vascular Compliance in Infants Jaeggi E., Shah J., Keating S., Kingdom J., Bradley T., Keeley F., Redington A.
P-50 Physical Examination: The Oldest but Still an Up-to-Date Diagnostic Method Kula S., Pektas A., Cevik A., Taskin B.D., Oguz A.D., Tunaoglu F.S., Olgunturk R. P-51 Catheter Haemodynamic Assessment with Pharmacological Stress to unmask Obstruction of the Fontan
CirculationManne P., Bhole V., Stumper O.
P-52 Predictors of parental quality of life after child open-heart surgery: a 6-months prospective study Landolt M.A., Valsangiacomo Buechel E.R., Latal B.
P-53 Interest of beta-blockers in patients with right ventricular systemic dysfunction Bouallal R., Godart F., Richard A., Francart C.
P-54 Beta-blocker therapy improves diastolic function and reduces hypertrophy in asymptomatic childhood familial hypertrophic cardiomyopathyÖstman-Smith I., de-Wahl Granelli A., Allahyari P.
P-55 Quality of life in children, adolescents, and young adults with congenital heart disease Henzinger H., Stein J.-I.
48
P-56 Analytical comparison for the case de� nition of elevated type-b amino-terminal pro-natriuretic peptide in acute Kawasaki disease
Dahdah N., Fournier A., Cousineau J., Delvin E., Mir T., Nir A.
P-57 Dysphagia lusoria caused by Aberrant right subclavian artery in severity is as same as complete vascular ring in schoolchildren: validated by Esophageal ManometryChen F.L., Kuo S.M., Li Y.C.
P-58 E� ects of Endothelin-Receptor-Antagonism on Left Ventricle and Arterial Blood Pressure in Children with Pulmonary Arterial Hypertension
Baumgartner S., Salzer-Muhar U.
P-59 Coronary artery ostial anomalies in common arterial trunk Houyel L., Bajolle F., Bonnet D.
P-60 Home INR monitoring of oral anticoagulation in children using a point-of-care INR monitor Bajolle F., Lasne D., Elie C., Souillard P., Bonnet D.
P-61 Prediction of tilt test results based on patient’s history in children with neurocardiogenic syncope Wieniawski P., Janiec I., Werner B.
P-62 The reference values of aortic pulse wave velocity (PWVao) in a healthy population aged 3-18 years and the plausible physiological background of the observed changesHidvégi E., Huberth J., Jákli Gy., Kelemen I., Klemencz H., Illyés M.
P-63 Incidence and risk factors of restenosis after surgery for subaortic stenosis Varan B, Gokdemir M., Tokel K., Cindik N., Ozkan S., Ozkan M., Aslamaci S.
P-64 Cardiovascular abnormalities in children with Alagille syndromeTurska-Kmiec A., Mirecka-Rola A., Zuk M., Biernatowicz M., Daszkowska J., Rewers B., Ziolkowska L., Kowalczyk M., Kawalec W., Jurkiewicz D, Zubrzycka M.
P-65 Non-invasive cardiac output determination in children with congenital AV block treated by ventricular pacing Wiegand G., Kerst G., Baden W., Hofbeck M.
P-66 The CIVIC Study: Hospitalizations for acute respiratory infections in young children with signi� cant heart disease. Four seasons (2004-2008) in Spain Medrano C., García-Guereta L., Grueso J., Insa B., Ballesteros F., Casaldaliga J., Cuenca V., Escudero F., Garcia-de la Calzada D.,Luis M., Mendoza A., Prada F., Rodriguez MM., Suarez P., Quero C., Rueda F., Gomez H.
P-67 Longitudinal data on ascending aortic dimension in Turner patientsFournier A., Hugues N., Brugada G., Mivelaz Y., Deal C., Thambo J.B., Dahdah N.
P-68 Steroids and Vascular Resistance Reducing Agents Improve Cardiac Outcome and Survival in Patients with Duchenne Muscular Dystrophy Fournier A., Thérien J., Schram G., Dahdah N.
P-69 Doppler tissue imaging analysis of right ventricular myocardial velocities in the third trimester fetuses and normal neonates – preliminary study Hamela-Olkowska A., Bokiniec R., Dangel J.H.
P-70 Acute rheumatic fever outcomes in 602 children; Kayseri/Türkiye experience Narin N., Mutlu FT., Baykan A., Hanedan Onan S., Sezer S., Uzum K., Baykan Z.
P-71 Surgical treatment of aortic coarctation within the � rst year of life: a 10 year review (clinical, surgical, biomechanical aspects)Teivane E., Lacis A., Ozolins V., Smits L., Sikora N., Bergmane I.
P-72 Williams Beuren syndrome may present as neonatal coarctationKammache I., Acar P., Amedro P., Fouilloux V., Ou P., Kreitmann B., Fraisse A.
P-73 Severe pulmonary hypertension in bronchopulmonary displasia: high incidence of associated cardiovascular abnormalitiesCerro MJ., Deiros L., Labrandero C., Guereta L., Rubio D., Fernandez A., Burgueros M., Bret M., Barrio M., Martinez MC., Diaz C., Menendez J.
P-74 Intramyocardial Injection of Autologous Bone Marrow derived progenitor Cells in Case of Dilated Cardiomyopathy in Four Month Old Child Bergmane I., Lubaua I., Ozolins V., Lacis A. Narbute I., Jegere S., Ramata-Stunda A., Jakobsons E., Erglis A.
P-75 Congenital Heart defects in Kabuki Syndrome at North-Eastern Region of Romania Iordache C., Luca A.C., Panzaru M.C., Volosciuc M., Braha E., Moisa S.M.
49
P-76 Romanian Study on Arterial Hypertension Prevalence and Cardiovascular Risk Factors on 5290 Children and AdolescentsCinteza E., Gherghina I., Anca I., Iagaru N., Matei D.
P-77 Morphometric analysis of coronary arteries after arterial switch procedure for transposed great arteries Moll M., Michalak K.W., Moll J.A., Moszura T., Kopala M., Młudzik K., Moll J.J.
P-78 Incidence of congenital heart disease in a series of outpatients referred to a tertiary level pediatric cardiac centerKristo I., Lunardini A., De Lucia V., Recla S., Ait-Ali L., Spadoni I., Giusti S., Biagini A.
P-79 Health- related quality of life in patients with congenital heart disease – comparison with healthy children and adolescentsToussaint-Götz N., Vahsen N, Kaestner M., Hombach A., Kallenberg R., Zartner P., Wiebe W., Schneider M.
GUCH and outcomes
P-80 Determining the Approaches to Facilitate the Patent Ductus Arteriosus Closure procedure with Amplatzer Duct Occluder Device in Adult Patients Pac F.A., Polat T.B., O ́az M.B., Balli S., Kibar E., Ece I.
P-81 When is the right time for MRI in patients after TOF correction?Kantorova A., Kaldararova M., Neuschl V., Nosal M., Masura J., Hraska V.
P-82 Psychosocial Adjustment and Proneness to Psychopathology in Adolescents and Young Adults with Congenital Heart Diseases (CHD) Vieira D., Proença C., Areias M.E.G., Silva A.M., Vaz C., Viana V., Moura C., Areias J.C.
P-83 Medical attendance of adult patients with congenital heart diseaseBauer U., Niggemeyer E., Vigl M., Paulick M., Lux A.
P-84 Testing a new disease speci� c quality of life measure for children and adolescents with heart disease in the United Kingdom (UK) Wray J., Franklin R., Brown K., Casale L., Guy S., Blyth J., Cassedy A., Marino B.
P-85 Aortic valve-sparing operations for ascending aortic aneurysmal disease: promising midterm results in young patients with congenital cardiovascular pathologyFrancois K., Bove T., Van Belleghem Y., De Backer J., De Wolf D., Suys B., Van Nooten G.
P-86 Prevalence of re� ex, vaso-vagal syncope in young adults long term follow-up correction of d-transposition of great arteries by Senning atrial switch Pietrucha A.Z, Pietrucha B.J., Czubek U., Mroczek-Czernecka D., Wegrzynowska M., Piwowarska W., Nessler J.
Imaging / functional assessment
P-87 Early changes in Right Ventricular Function and their Clinical Consequences in Childhood Dilated CardiomyopathyGrosse-Wortmann L., Roche S.L., Yoo S.-J., Seed M., Kantor P.
P-88 Utility of Whole-Blood Aggregation for Evaluation of Anti-Platelet Therapy in Chronic Stage of Kawasaki DiseaseSuzuki C., Yahata T., Hamaoka A., Fujii M., Ozawa S., Hamaoka K.
P-89 Complete anatomical and physiological assessment of partial anomalous pulmonary venous connection with MRIGrosse-Wortmann L., Seller N., Grant B., Yoo S.
P-90 Quanti� cation of left to right shunt through patent ductus arteriosus by color Doppler-Clinical and experimental studiesHarling S., Jansson T., Pesonen E.
P-91 Tissue Doppler Imaging study in long-term follow-up of patients who underwent surgical mitral valvuloplasty in pediatric age Milanesi O., Varotto E., Bi® anti R., Maschietto N., Padalino M., Vida V., Stellin G.
P-92 Changes of natriuretic peptide type B levels after exercise in children with congenital heart defects compared with healthy childrenHolmgren D., Westerlind A., Lundberg P.A., Wåhlander H.
P-93 Assessment of ventricular function and dyssynchrony before and after stage II operation for hypoplastic left heart syndrome using 2D speckle tracking Petko C., Ho® mann U., Möller P., Kramer H.-H., Uebing A.
50
P-94 Increased left atrial performance in asymptomatic patients and ventricular analysis of diastolic function in children after ToF-RepairKoenigstein K., Hurst T., Hosse M., Hauser M., Abdul-Khaliq H.
P-95 Early detection of anthracycline cardiotoxicity in children with cancer using plasma levels of NT proBNP and pulsed-tissue Doppler echocardiography Atalay S., Uçar T., Tutar E., Uysal Z., Yavuz G.
P-96 The use of advanced imaging modalities in the management of patients with congenital heart disease – a European multicenter survey Valsangiacomo Buechel E.R., Hoesli D., Mertens L., Helbing W.A., Simpson J.M., Sieverding L., Milanesi O.
P-97 Added value of Real-time Three-dimensional Trans-thoracic Echocardiography in the Assessment of Congenitally Malformed Aortic valve Al-Barakati M., Anwar A.M., Nosir Y.F.,Galal A.N.,Chamsi-Pasha H.
P-98 Integrated assessment of diastolic and systolic ventricular function using diagnostic MRI-catheterization: Validation in pigs and application in a clinical pilot study Kuehne T., Schmitt B., Steendijk P., Lunze K., Ovroutski S., Falkenberg J., Rahmanzadeh P., Maarouf N., Ewert P., Berger F.
P-99 Use of Monoplane Intracardiac Echocardiographic Transducer as a Transesophageal Probe in Low – Weight Infants Undergoing Complex Congenital Heart Surgery: Feasibility and E� ectiveness Arcidiacono C., Micheletti A., Piazza L.P., Negura D.G., Butera G., Chessa M., Frigiola A., Carminati M.
P-100 Comparison of Radiation Dose in Paediatric Diagnostic Cardiac Catheter and Cardiovascular CT AngiographyNarayanan A., Tawil M.
P-101 Detection of coronary complications after coronary reimplantation surgery: � rst experience with multislice computer tomography in children Marini D., De¶ lippi C., Di Rosa G., Abbruzzese P., Agnoletti G.
P-102 Sti� ness and Wall Motion Velocities of Abdominal Aorta Measured by Tissue Doppler Imaging in Obese ChildrenGurses D., Ozyurek A.R., Ulger Z., Coker M., Darcan S., Levent E.
P-103 Altered Biophysical Properties of the Aorta Following Kawasaki Disease Dahdah N., Fournier A., Houde C., Sandor G.
P-104 Surgical correction of congenital heart disease has no in� uence on left ventricular dyssynchrony Klitsie L, Hazekamp M.G., Gesink-Van der Veer B.J., Blom N.A., Ten Harkel A.D.J.
P-105 Myocardial velocities and 2-d strain in 26 healthy children and adolescents before and immediately after a triathlonSchön P., Petzuch K., Kühn A., Elmenhorst J., Röhlig Ch., Schönfelder M., Oberho® er R., Vogt M.
P-106 Two Dimensional and Color Doppler Derived Systolic Strain in Children: a Comparison Study using 2 Di� erent Ultrasound Systems and 3 Analysis Software PackagesKoopman L.P., Slorach C., Manlhiot C., McCrindle B.W., Friedberg M.K., Jaeggi E.T., Mertens L.
P-107 Echocardiographic evaluation of right ventricle function after percutaneous balloon valvuloplasty in infants with pulmonary valve stenosis Khanenova V.A., Kurkevych A.K., Maksymenko A.V., Boyko O.P., Stogova O.V., Rudenko N.M., Yemets I.M.
P-108 Two Dimensional and Color Doppler Derived Radial Strain Rate in Children: a Comparison using 2 Ultrasound Systems and 3 Analysis Software Packages Koopman L.P., Slorach C., Manlhiot C., McCrindle B.W., Jaeggi E.T., Friedberg M.K., Mertens L.
P-109 Tissue Doppler Velocity Imaging in Children: a Comparison Between two Ultrasound Systems Koopman L.P., Slorach C., Manlhiot C., McCrindle B.W., Friedberg M.K., Mertens L., Jaeggi E.T.
P-110 Evaluation with Echo-Dipyridamole or supine bicycle exercise stress echocardiography to auhorize physical activity without restriction in patients with a history of Kawasaki diseaseDe Lucia V., Mazzoni A.M., Terrazzi, Lunardini A., Recla S., Spadoni I., Giusti S.
P-111 Left and right ventricular deformation and mechanical dyssynchrony in young patients after repair of Tetralogy of FallotFriedberg M.F., Fernandes F.P., Roche S.L., Fackoury C., Kantor P.F.
P-112 Usefulness of cardiovascular magnetic resonance in children with suspected myocarditis Werner B., Piotrowska Kownacka D., Kownacki L., Wojcicka Urbanska B., Rowinski O.
51
P-113 Evaluation of Left Ventricular Force Frequency Response Using Systolic Tissue Velocities and Radial Strain in a Novel Rabbit Model of Heart Rate Dependent Contractile RemodelingSlorach C., Mertens L., Hui W., Jiang J., Gross G., Friedberg M.
P-114 Intraventricular Timing of Strain and Strain Rate in healthy childrenLaser K.T., Hau® e P., Beck C., Haas N., Kececioglu D., Körperich H.
P-115 Assessment of global and regional volumes by RT3DE and CMRLaser K.T., Barth P., Beck C., Haas N.A., Kececioglu D, Burchert W., Körperich H.
P-116 Preserved aortic elasticity in patients with Marfan syndrome during � ve years of follow-up Baumgartner D., Baumgartner C., Karall T, Schweigmann U, Stein J.-I.
P-117 Value of exercise systolic blood pressure and systolic pressure gradient in assesment of children after repair of coarctation of the aorta Djukic M., Vukomanovic G., Ilisic T., Stefanovic I., Dabetic M., Ilic S., Jovanovic I.
P-118 Right ventricular function assessed by Tissue Doppler imaging before and after transcatheter closure of atrial septal defect Laskari C.V., Kia® as M.G., Tsutsinos A.I., Rammos S.
P-119 Echocardiographic morphological parameters for detection of the coarctation aorta in neonatesIlisić T., Ilić S., Parezanović V., Đukić M., Vukomanović G., Stefanović I., Raus M., Vulićević I., Jovanović I.
P-120 Strain Rate Imaging for the Evaluation of Left Ventricular Function after Patent Ductus Arteriosus Closure
Ghonimy R., Adel M., Hegab M., Khairee E.
Interventional cardiology
P-121 Use of the new Amplatzer duct occluder II in comparison with Amplatzer duct occluder – single center experience Venczelova Z., Masura J., Tittel P.
P-122 Clinical, echocardiographic and histopathologic � ndings in nine patients with surgically explanted ASD/PFO devices: Do we know enough about the healing process in humans?Vogt M., Kühn A., Hörer J., Schreiber Ch., Schneider H., Foth R., Hess J., Sigler M.
P-123 The Italian Society of Pediatric Cardiology Registry on transcatheter Melody pulmonary valve implantationButera G., Milanesi O., Piazza L., Donti A., Spadoni I, Giusti S, Formigari R.,Ricci M., Pongiglione G., Papa M., Pangrazi A., Carminati M.
P-124 Aortic coarctation associated with wall aneurysm : The role of covered stent Butera G., Heles M., Shridar A., Piazza L.,Negura D., Chessa M., Micheletti A., Arcidiacono C., Abella R., Giamberti A., Pomè G., Bussadori C., Frigiola A., Carminati M.
P-125 Italian Patent Foramen Ovale Survey (I.P.O.S.): early resultsButera G., Sangiorgi G., Lucarelli K., Ussia G., Aprile A., Spadoni I., Onorato E., Caputi L., Benassi A., Chessa M., Ramondo A., Anzola G., Zanchetta M., Bortone A., Santoro G., Vignati G., Rigatelli G., Presbitero P., Pierli C., Varotto L., Papa M., Colombo A., Carminati M.
P-126 Five-year Follow-up After Balloon Pulmonary And Aortic Valvuloplasty In Benghazi Cardiac Center Feituri R, Rahuma S., Gobhaa N., Kasmi A.
P-127 A comparative study on validation of a novel device for percutaneous closure of atrial septal defects: Figulla ASD Occluder versus Amplatzer Septal Occluder Pac F.A., Polat T.B., O ́az M.B.,Topaloglu S., Balli S.,Cetin I.I.Kibar E., Ece I.
P-128 Atrial Septal Defect Occlusion by the Transcatheter Patch: Can Patch Release Time In� uence the Results?Sideris E., Zanjani K., Zeinalloo A., Kalachanis M.,Coulson J., Sideris B., Pursanov M., Kumbasar D.
P-129 Immediate and long-term results of balloon aortic valvuloplasty of congenital valvular aortic stenosis in 98 patientsGamillscheg A., Mileder L.P., Knez I., Koestenberger M., Heinzl B., Fandl A., Finding K., Fritsch P., Nagel B.
P-130 Reduction of right ventricular afterload improves right ventricular function Kaestner M., Schneider K., Toussaint-Götz N., Wiebe W., Zartner P., Schneider M.B.E.
P-131 Percutaneous aortic valvuloplasty in patients older than 1 month with congenital aortic valve stenosis: a good alternative to surgery Corzani A., Donti A., Formigari R., Bronzetti G., Balducci A., Fabi M., Testa G., Bonvicini M., Picchio F.M.
52
P-132 Stent Expansion of Stretch Gore-Tex® Grafts in Children with Congenital Heart LesionsGewillig M., Brown S.C., Bosho® D.E., Heying R., Goren ́o M., Rega F., Eyskens B., Meyns B.
P-133 Bailout stenting for critical coarctation in premature/ critical/complex/early re-coarcted neonates Gewillig M., Bosho® D.E., Heying R., Eyskens B., Rega F., Meyns B., Goren ́o M.
P-134 Stent Implantation in Newborns an Infants: A Current RealityFerreira Martins J.D., Costa G., Gouveia S., Parames F., Freitas I., Rebelo M., Trigo C., Pinto F.
P-135 Stenting of native and re-coarctation with a new chromium-cobalt stent (Andra Stent ®) in children and young adultsBeck C., Laser T.K., Kececioglu D., Haas N.A.
P-136 Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT studyKitzmüller E., Hanslik A., Karapetian H., Salzer-Muhar U., Michel-Behnke I., Male C.
P-137 Outcome of device closure of ASD in intermediate and long termSadiq M., Kazmi T., Rehman A.U., Latif F., Hyder N., Qureshi S.A.
P-138 Our Experience of ADO2 Device Occlusion of PDA Narayanan A., Mehta C., Ladusans E., Gladman G., Misra S., Peart I.
P-139 Balloon angioplasty of branch pulmonary arteries following arterial switch operation for transposition of great arteries: Is it e� ective? Shastri A., Naqvi N., Maiya S., Magee AG.
P-140 Electrocardiographic and Rhythm Changes Following Percutaneous Atrial Septal Defect Device Closure Hagler D.J., Johnson J.N., Marquardt M.L., Ackerman M.J., Asirvatham S.J., Reeder G.S., Cabalka A.K, Cetta F.
P-141 The Role of Real-Time Three-Dimensional Transoesophageal Echocardiography in Guiding Device Closure of Atrial Septal Defect in Children Chen F.L., Kuo S.M., Liao C.P., Weng C.Y.
P-142 Five years follow-up of stenting of aortic coarctationBrzezińska-Rajszys G., Zubrzycka M., Rewers B., Książyk J., Jagiełłowicz D., Kościesza A., Kansy A.
P-143 Transcatheter recanalization of occluded modi� ed Blalock-Taussig shunts Rewers B., Brzezińska-Rajszys G., Zubrzycka M., Książyk J., Kansy A., Birbach M., Zuk M.
P-144 Aorto-pulmonary collaterals causing complicated postoperative course after cardiac surgery – results of percutaneous treatment Zubrzycka M., Brzezinska-Rajszys G., Rewers B., Ksiazyk J., Kansy A., Birbach M., Ziolkowska L.
P-145 Occlusion of Fontan fenestrations using Amplatzer Duct Occluder II Briales C., Zunzunegui J.L., Ballesteros F., Alvarez T., Maroto E., Centeno M., Medrano C.
P-146 Transcatheter closure of atrial septal defects with transthoracic echocardiography Şahin M., Özkutlu S., Karagöz T., Yıldırım I., Çeliker A., Alehan D., Özer S.
P-147 Interventional palliation of a patient with isolated left pulmonary artery: clinical course and histopathology Koch A., Cesnjevar R., Dittrich S., Breuer C., Zink S., Glöckler M., Sigler M.
P-148 Long term follow-up of transcatheter closure of atrial septal defects for paradoxical embolism with the Helex Septal Occluder: a contrast-enhanced transcranial Doppler studyLunardini A., Recla S., Ait-Ali L., Chiappino D., Monteleone A., De Lucia V., Kristo I., Spadoni I.
P-149 Experience with hybrid pulmonary valve replacement in an acute pig model Schmitz C., Thalmann R., Merkel E., Bombien R., Akra B., Aleksieva G., Negaoie A., Fano C., Dauner M., Sodian R., Lang N., Breuer J., Neuss M., Reichart B., Kozlik-Feldmann R.
P-150 Right ventricular out� ow tract stent implantation as a primary palliation in patients with Tetralogy of FallotReinhardt Z., Stumper O., Miller P., Stickley J., Viswanathan S., De Giovanni J.V.
P-151 A new device (Cardi-O-Fix muscular ventricular septal defect occluder) for percutaneous closure of congenital muscular ventricular septal defects : early results Akdeniz C., Sarıtas T., Erdem A., Odemis E., Demir F., Demir H, Celebi A.
P-152 Cheatham-Platinum Stents for Aortic Coarctation: Immediate and Early Results Erdem A., Celebi A., Akdeniz C.,Sarıtaş T., Erol N., Demir H., Yalcin Y.
53
P-153 Transcatheter closure of congenital ventricular septal defects (vsd) with various devices and coils; early and mid-term resultsCelebi A., Akdeniz C., Zeybek C., Erdem A., Sarıtaş T., Demir H., Erol N., Imanov E., Yalcın Y.
P-154 Lead removal in children and young adults with a congenital heart disease Zartner P., Wiebe W., Toussaint-Götz N., Schneider M.
P-155 Novel pre-mounted balloon expandable graft stent (Avanta V12) expands interventional options to treat cardio-vascular obstructionsSchranz D., Jux Ch., Hagel K.-J., Bauer J., Valeske K., Akintürk H.
P-156 Up to 7-year Follow-up after Transcatheter Closure of Paravalvar Leaks Radtke W.A.K., Bandisode V.M., O´Murchu B.
P-157 Percutaneous closure of atrial septal defects in children: what are the limits? Barre E., Petit J., Losay J., Capderou A., Piot J.D., Stos B., Legendre A., Serraf A., Lambert V.
P-158 Haemoptysis after the Fontan procedure: Coil embolisation of aortopulmonary collaterals Ahmad Z., Lim Z., Kiesewetter C., Veldtman G., Vettukattil J.J.
P-159 Transcatheter closure of ventricular septal defects with the Amplatzer Duct Occluder II (ADO II) Bauch A., Reinhardt Z., Miller P., De Giovanni J.
P-160 Stent Implantation for the Treatment Aortic Coarctation in Children: Initial and Five-Year Results Thanopoulos B.D., Tsaousis G.S.
P-161 Cardiac Catheter Guiding Surgical Closure of Muscular VSDZunzunegui J.L., Ballesteros F., Alvarez T., Centeno M., Camino M., Medrano C., Maroto E., Briales C., Panadero E., Greco R.
P-162 Midterm results of stented coarctation: A follow - up study of 90 patients Fakler U., Eicken A., Genz Th., De Pasquale-Meyer G., Hess J.
P-163 Interventional catheterization in the management of di� use congenital pulmonary vein stenosis in the infants and small childrenkammache I., Fouilloux V., Quilici J., Cuisset T.,Bonello B., Macé L., Kreitmann B., Fraisse A.
P-164 Percutaneous closure of atrial septal defects in patients with right ventricular out� ow tract (RVOT) obstruction: indications and results Recla S., Ait-Ali L., Lunardini A., De Lucia V., Giusti S., Spadoni I.
P-165 Emergent use of extracorporeal membrane oxygenation during pediatric cardiac catheterization Ballesteros F., Zunzunegui J.L., Briales C., Alvarez T., Maroto E., Brochet G., Greco R.
P-166 The Amplatzer duct occluder type II (ADO II): a versatile device – especially outside the duct Jux C., Mebus S., Mazhari N., Hagel K, Schranz D.
P-167 Percutaneous right out� ow tract valve implantation: when is right moment for pre-stenting? Brugada G., Kammache I., Iserin L., Fraisse A., Boudjemline Y.
P-168 Percutaneous right out� ow tract valve implantation: substrate matters Brugada G., Kammache I., Iserin L., Fraisse A., Boudjemline Y.
P-169 Novel Technique to reduce the Size of a Fontan Diabolo Stent FenestrationAnderson B.W., Bhole V., Desai T., Mehta C., Stumper O.
Surgery and Intensive care
P-170 Surgical Correction of HOCM in Patients with Extreme Hypertrophy and Septal Myocardial Fibrosis Borisov K.V.
P-171 Operative Treatment Analysis of Patients with Anomaly Ebstein and Determination of Unfavorable Predictors for Surgical Repair Savitskaya N.V., Matusevich I.D.
P-172 Critical aortic valve stenosis : prognosis and in� uence of � rst intervention on outcomes Di Filippo S., D’Agata B., Henaine R., Sassolas F., Ducreux C., Ninet J., Bozio A.
P-173 Early measurement of plasma neutrophil gelatinase associated lipocalin (NGAL) to screen for acute renal
injury after cardiac surgery Koch A., Glöckler M., Cesnjevar R., Zink S., Dittrich S.
54
P-174 Brachial artero-venous � stula in high risk patients for Fontan’s operation Quarti A., Oggianu A., Cetrano E., Colaneri M., Baldinelli A., Pozzi M.
P-175 Secondary pulmonary valve implantation after repair of Tetralogy of Fallot. Factors in� uencing the incidence and timing of the reoperation Nagy Z., Wiegand G., Sieverding L., Hofbeck M., Ziemer G.
P-176 Telemetric Pulmonary Artery Banding Helps Growth of Hypoplastic Aortic Annulus in Children with Parallel CirculationEnodien B., Comber M., Dave H., Balmer C., Prêtre R.
P-177 Mid-term results of valve sparing aortic root replacement in children with Marfan or Loeys-Dietz syndrome Rozendaal L., ten Harkel A.D.J., Ottenkamp J., Koolbergen D.R., Hazekamp M.G.
P-178 Inhaled nitric oxide for postoperative elevated pulmonary arterial pressure after Fontan-type operations Georgiev S., Lacheva A., Pilosso® V.
P-179 Neurodevelopmental outcome after hybrid procedure in children with functional hypoplastic left heart syndrome Liamlahi R., Knirsch W., Bürki C., Prêtre R., Bernet V., Latal B.F., Kretschmar O.
P-180 Biomechanical properties and application of glutaraldehyde treated human pericardium in congenital heart surgeryOzolins V., Smits L., Sikora N., Teivane E., Bergmane I., Kasyanov V., Ozolanta I.,Lacis A.
P-181 Valve insertion for a dysfunctional pulmonary valve secondary to a Primary Congenital Heart Repair Dave H., Comber M., Balmer C., Enodien B., Nikolaou G., Trigotrindade P., Pretre R.
P-182 Risk factors for early morbidity after extracardiac Fontan operationOvroutski S., Miera O., Alexi-Meskishvili V., Hübler M., Ewert P., Hetzer R., Berger F.
P-183 Medium-term outcome following Ross/Ross-Konno operation in very young children Maiya S., Naqvi N., Damda F., Chubb H., Moledina S., Sethia B., Shore D., Slavik Z.
P-184 The Use of Arginine Vasopressin in Postoperative Norwood PatientsBurton G., Goot B.,da Cruz E.,Kaufman J.
P-185 Early postoperative outcomes following surgical repair of complete atrio-ventricular septal defects (CAVSD): Is trisomy 21 a risk factor? Desai A., Maiya S., Comitis G., Vyas D., Slavik Z., La Rovere J.
P-186 Tetralogy of Fallot: changing practice in perioperative careDesai A., Sainath R., Davies L., Slavik Z., Halley E.
55
SOCIAL PROGRAMME
Welcome ReceptionWednesday, 26 May 201018.00-20.00h
Subsequent to the opening session, featuring the “Mannheimer Lecture” by Philipp Bonhoeffer and musical interludes, all attendees are invited to the Welcome Recep-tion in the Exhibition Area. Participants from all over the world, exhibitors and local guests meet at the Tirol and Kristall Foyer of the Congress Innsbruck to celebrate the start of a fruitful conference. Local snacks and drinks will be served.
AEPC Gala-DinnerFriday, 28 May 201019.00 – 23.00h. Meet at the entrance foyer of the Congress Innsbruck
Come and meet your friends and colleagues at the AEPC gala evening. Enjoy an elaborate evening amidst the historical setting of the Giant’s Hall of the Imperial Palace Innsbruck, located only a few walking minutes from the congress centre. Prior to the dinner, all delegates will be greeted and accompanied by the Imperial Tiroler Kaiserjäger Brass Band to the Inner Court of the Imperial Palace, where a soiree at the court of Emperor Maximilian I will be staged. Due to the limited size of the Giant’s Hall, attendance for the gala dinner is based on a fi rst-come-fi rst-served basis.
56
TOURS AND EXCURSIONSPost congress tour: Lake Achensee, the “Tyrolean Fjord«Saturday, May 29, 201014:30 - 22.00 hrs w 105,00
The region around lake Achensee is embedded between the Karwendel alpine park, the most beautiful nature reserve in the limestone Alps and the Rofan mountain range with its unique alpine fl ora and fauna – a perfect setting for hikers. It is situated some 45 km to the east of Innsbruck on a high plateau. 9.4 km long and 1 km wide, Achensee is the largest lake in the Tyrol and is often compared to the Norvegian Fjords. It is also called “the Tyrolean pearl”. We start from Innsbruck by bus to go Jenbach. From there we will take the steam locomotive to go up to lake Achensee. After our 7 km adventurous ride on one of the oldest steam locomotives, we arrive at lake Achen-see and go aboard a steam-ship. Experience the magic
spell of this lake which is embedded in between the Karwendel and Rofan mountains.
Excursions for accompanying personsInnsbruck City Tour Thursday, May 27, 201009:30 - 12:00 hrsw 18,00
Our local tour guide fi rst takes you on a walking tour through the charming Old City of Innsbruck, situated next to the river Inn which gave its name to the city. Take a closer look at its numerous historical land-marks, such as the Hofkirche church with its »Black Knights« surrounding the funeral monument of Emper-or Maximilian, the Rococo-style Helbling town house,
St. Jacob‘s Cathedral and, above all, the Little Golden Roof. We then visit the ex-cellent museum of Tyrolean Folk Art which will give you a close insight into the life and culture of our Tyrolean ancestors. The museum features among others traditional furniture, costumes and household utensils.
57
Swarovski crystal worlds and the medieval city of HallFriday, May 28, 201009:00 - 13:00 hrsw45,00
A bus takes us through a number of typical Tyro-lean villages to Wattens, where the Swarovski Crystal Worlds opened their doors to the public some 10 years ago. Through the huge water-spouting head of a bo-tanic giant the visitor enters the mostly subterranean, unique magic World of Crystal. »This place is like a
fairy tale come true. People suddenly experience what they previously knew only in their dreams«, says Viennese multimedia artist André Heller, creator of the Swarovski Crystal Worlds. You have to experience yourself what is hard to describe: a view of the surreal landscape of a glittering galaxy, the inside of a gigantic crystal dome with changing patterns of light and sound, bizarre scenarios - a world of magic. You will have time to look for a souvenir in the crystal shop or enjoy a cup of coffee and a delicious Austrian cake. After a short bus ride we reach the medieval city of Hall with its Mint Tower.The fi rst records of Hasegg Castle and its famous Mint Tower (»Münzturm«) date back to 1306. Its original purpose was to protect the nearby salt-storage houses. When Archduke Ferdinand II had the old mint transferred from the Castle of Sparberegg to Hasegg in 1567, Hall experienced a decisive upswing. The minting of silver-talers in Hall became world famous.
A feeling for nature – adventure in the Tyrolean Mountains Thursday, May 27, 201014:30-17:30 hrs w 48,00
Within only a few minutes from Innsbruck you are amidst the impressive scenery of the high mountain area surrounding the city. The new cable railway starts right next to the Congress Innsbruck and takes you up to Hungerburg at 800m above sea level and then on by
gondola to the Seegrube peak (1.905 m above sea-level). This is one of the fi nest hi-king and skiing regions around Innsbruck, with truly challenging slopes. In summer, the view down into the valley and the glaciers further behind is truly spectacular - an unforgettable experience!
58
FIKU \ Sortis 10 mg/20 mg/40 mg/80 mg - Filmtabletten 1 R 01 & R 02 / 2007 04 25 / 2007 06 19 Austria
Fachkurzinformation
Sortis® 10 mg/20 mg/40 mg/80 mg - Filmtabletten
Zusammensetzung: 1 Filmtablette enthält 10 mg/20 mg/40 mg/80 mg Atorvastatin (als Atorvastatin-Calcium-(Trihydrat)). Hilfsstoffe: Sortis 10 mg/20 mg/40 mg: Calciumcarbonat, mikrokristalline Cellulose, Lactose-Monohydrat, Croscarmellose-Natrium, Polysorbat 80, Hydroxypropylcellulose, Magnesiumstearat. Filmüberzug: Hypromellose, Macrogol 8000, Titandioxid (E 171), Talkum, Simethiconemulsion [USP], Stearat-Emulgatoren, Sorbinsäure, Candelillawachs. Sortis 80 mg:Calciumcarbonat, mikrokristalline Cellulose, Lactose-Monohydrat, Croscarmellose-Natrium, Poly-sorbat 80, Hydroxypropylcellulose, Magnesiumstearat. Filmüberzug: Hypromellose, Macrogol 8000, Titandioxid (E 171), Talkum, Simethiconemulsion [USP], Stearat-Emulgatoren, Sorbinsäure. Anwendungsgebiete: Hypercholesterinämie: Die Anwendung von Sortis ist zusätzlich zu einer Diät angezeigt zur Senkung erhöhter Gesamtcholesterin-, LDL-Cholesterin-, Apolipoprotein B- und Triglyzeridspiegel bei Patienten mit primärer Hypercholesterinämie, einschließlich familiärer Hypercholesterinämie (heterozygote Variante) oder kombinierter (gemischter) Hyperlipidämie (entsprechend Typ II a und II b nach Fredrickson), wenn Diät und andere nicht pharmakologische Maßnahmen keine ausreichende Wirkung erbringen. Sortis ist auch zur Senkung von Gesamt- und LDL-Cholesterin bei Patienten mit homozygoter familiärer Hypercholesterinämie angezeigt - entweder zusätzlich zu anderen lipidsenkenden Maßnahmen (z. B. LDL-Apherese) oder falls solche Behandlungsmöglichkeiten nicht verfügbar sind. Vorbeugung kardiovaskulärer Erkrankungen: Zur Vorbeugung kardiovaskulärer Ereignisse bei Patienten, deren Risiko für ein erstes kardiovaskuläres Ereignis als hoch eingestuft wird, zusätzlich zur Behandlung weiterer Risikofaktoren (siehe Abschnitt 5.1 der Fachinformation). Gegenanzeigen: Sortis ist kontraindiziert bei Patienten • mit Überempfindlichkeit gegen den Wirkstoff oder einen der sonstigen Bestandteile des Arzneimittels •mit aktiver Lebererkrankung oder unklarer, dauerhafter Erhöhung der Serumtransaminasen auf mehr als das 3fache des oberen Normalwertes • mit Myopathie • in der Schwangerschaft • während der Stillzeit • bei Frauen im gebärfähigen Alter, die keine geeigneten Verhütungsmethoden anwenden. Inhaber der Zulassung: Pfizer Corporation Austria Ges.m.b.H., Wien. Stand der Information:April 2007. Verschreibungspflicht / Apothekenpflicht: Rezept- und apothekenpflichtig. Infor-mationen zu Warnhinweisen und Vorsichtsmaßnahmen für die Anwendung, Wechselwirkungen mit anderen Mitteln, Schwangerschaft und Stillzeit und Nebenwirkungen sind der Austria-Codex-Fachinformation zu entnehmen.
Fachkurzinformation zu Seite 42
59
EXHIBITORS AND SPONSORSSponsors (including Sponsors of unrestricted Educational Grants) and Exhibitors:
ABBOTT GesmbHACTELION Pharmaceuticals LtdACTIOPHARM GmbHAGA Medical CorporationAmomed Pharma GmbHBank Austria – Member of UniCreditGroupBAYER AUSTRIA GmbHBIOMEDICA Medizinprodukte GmbH & Co KGBoston Scientifi cEdwards Lifesciences S.A.GE HealthcareHIPP GmbH & Co. Vertrieb KGHypo Tirol Bank AGINTERVENT Handels GmbHKompetenznetz angeborene HerzfehlerMEDTRONICMILUPA GmbHMULTIPLATENOVOMED Handels-GesmbHNuMED Inc.OSYPKAPFIZER Corporation Austria GmbHPhilips Medical Systems/ Philips Cardiovascular UltrasoundSiemens AGST. JUDE MEDICALSwissimplant AGTom Tec Imaging Systems GmbHWERFEN AUSTRIA GmbHWisepress Ltd.W.L. Gore & Associates, S.L.Zenicor Medical Systems
Thank you very much for supporting the AEPC Meeting 2010!
AMPLATZER® is a registered trademark of AGA Medical.© AGA MEDICAL CORPORATION, 2010.
Not in any way connected with medical gas or equipment sold under the “AGA” brand by AGA AB or its successors.
A Review of My Complex ASD CasesMario Carminati, MD I.R.C.C.S. Policlinico San Donato, Italy13:00 – 13:25 hrs
ASD Tips & Tricks: Greatest Challenges for Implanting MDsChristian Jux, MDUniversity of Gießen and Marburg, Germany 13:25 – 13:50 hrs
Question and Answer Session13:50 – 14:00 hrs
Advanced ASD Closure Featuring the AMPLATZER® Septal Occluder
AMPLATZER® Septal Occluder
44th ANNUAL MEETING • Innsbruck, Austria
ASSOCIATION FOREUROPEAN PAEDIATRIC CARDIOLOGYAGA Medical Symposium Friday, May 28th, 2010 • 13:00 – 14:00 hrs • Hall Innsbruck
![What is Why is it paediatric different to adult cardiology? · different to adult cardiology? ... Atrial septal defect ... [sex determining region Y]-box 4) AVSD, TGA, semilunar valve](https://img.dokumen.tips/doc/110x75/5ac1057c7f8b9a1c768c62c5/what-is-why-is-it-paediatric-different-to-adult-cardiology-to-adult-cardiology.jpg)
